Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017918	s-cmvab	— (—)	9250	13720	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cystic kidney disease

294

226

16.81

320.33

2.7

1.4

—

Unspecified kidney failure

381

423

9.76

315.70

2.4

1.2

—

Hypertensive diseases (excluding secondary)

1320

2260

3.49

311.63

2.2

1.2

—

Cystic kidney disease

295

240

15.53

309.86

2.7

1.4

—

Any gastric operation

2078

2461

4.35

307.65

1.6

1.2

—

Second line medication for Crohn's disease

1534

5065

3.13

307.65

1.7

1.4

—

Influenza and pneumonia

2439

6425

2.47

307.65

1.7

1.4

—

First line medication for Crohn's disease

3248

4703

3.86

307.65

1.8

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1950

4864

2.90

307.65

1.7

1.4

—

Liquid cancers, helper endpoint

1673

1992

7.92

307.65

1.4

1.5

—

ILD medications

3497

4722

4.16

307.65

1.9

1.2

—

Inflammatory bowel disease treatment related agents

2779

5980

2.66

307.65

1.6

1.5

—

Viral Sepsis

707

1194

6.31

307.65

2.1

1.3

—

ILD medications: azathioprine

678

927

7.97

307.65

2.1

1.2

—

Infections, IBD-co-morbidities

663

676

7.47

307.65

2.0

1.4

—

Cytomegaloviral disease

320

164

30.21

307.65

2.4

1.6

—

Other/unspecified cytomegaloviral diseases

291

134

36.38

307.65

2.5

1.5

—

Implicit Sepsis

1816

4206

3.35

307.65

1.7

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

3297

4564

4.19

307.65

1.9

1.2

—

Other septicaemia

1177

2095

5.68

307.65

2.1

1.3

—

2024

4581

2.74

307.65

1.6

1.4

—

Failure and rejection of transplanted organs and tissues

247

102

47.15

307.65

2.7

1.5

—

Cytomegalovirus infection, IBD co-morbidity

319

161

31.44

307.65

2.4

1.6

—

Heart failure, not strict

2173

3390

4.54

307.65

2.1

1.3

—

Donors of organs and tissues

235

48.87

307.65

1.7

1.2

—

ILD medications: immunosuppressive drugs

2942

4055

7.23

307.65

2.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2024

5214

2.74

307.65

1.7

1.4

—

Implicit bacterial Sepsis

1210

2289

4.76

307.65

1.8

1.3

—

Caries of dentine

1051

1507

7.35

307.65

2.2

1.3

—

Septicaemia

1288

2371

5.33

307.65

2.1

1.3

—

Extracorporeal dialysis

906

387

37.53

307.65

3.0

1.4

—

GASTRO-related operations

2078

2461

4.35

307.65

1.6

1.2

—

Dental caries

1200

1732

7.21

307.65

2.2

1.3

—

L04AX Other immunosuppressants

1453

4896

3.07

307.65

1.7

1.4

—

Implicit Sepsis

1892

4690

3.03

307.65

1.7

1.3

—

Non-follicular lymphoma

481

540

10.04

307.65

1.4

—

Bacterial infection, other or unspecified

1813

2903

5.71

307.65

1.8

1.3

—

Glomerular disorders in diseases classified elsewhere

786

763

12.07

307.65

2.7

1.3

—

Enlarged lymph nodes

712

903

8.57

307.65

1.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2024

4581

2.74

307.65

1.6

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2922

5426

3.85

307.65

1.7

1.4

—

Chronic kidney disease

1726

1504

12.60

307.65

2.6

1.2

—

Fever of other and unknown origin

2384

3333

6.77

307.65

1.6

1.4

—

Secondary hypertension

650

395

19.53

307.65

2.8

1.2

—

Implicit viral Sepsis

866

1799

5.05

307.65

1.9

1.3

—

Renal failure

2052

2277

8.64

307.65

2.4

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

1427

1367

11.84

307.65

1.4

1.5

—

Other diseases of blood and blood-forming organs, wide

807

1569

5.51

307.65

1.5

1.4

—

Disorders resulting from impaired renal tubular function

402

224

25.11

307.65

3.0

1.4

—

Dialysis

666

249

46.46

307.65

3.1

1.3

—

Implicit bacterial Sepsis

1154

2080

5.14

307.65

1.8

1.3

—

Renal tubulo-interstitial diseases

2552

5300

3.72

307.65

2.1

1.2

—

Azathioprine

678

1158

6.36

307.65

2.1

1.4

—

Bacterial Sepsis

1297

2474

4.67

307.65

1.8

1.3

—

Diseases of liver

1236

2515

5.22

307.65

1.3

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2854

5366

3.58

307.65

2.1

1.2

—

All chronic kidney diseases

2077

2986

6.04

307.65

2.4

1.2

—

Glomerular diseases

1047

1274

9.29

307.65

2.7

1.3

—

Other disorders of kidney and ureter

536

848

6.90

307.65

2.7

1.4

—

Preparatory care for dialysis

597

262

35.58

307.65

2.6

1.3

—

Care involving dialysis

1248

433

45.91

307.65

2.8

1.3

—

Other bacterial diseases

2715

5320

3.34

307.65

1.8

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes

427

453

10.62

307.65

1.4

—

General symptoms and signs

2698

4194

3.31

307.65

1.5

1.4

—

Explicit Sepsis

1337

2707

4.83

307.65

2.1

1.3

—

L04AD Calcineurin inhibitors

1719

772

35.15

307.65

2.7

1.2

—

Nephropathy related operations

1713

746

34.13

307.65

2.7

1.2

—

Other bacterial diseases

2673

4985

3.73

307.65

1.8

1.4

—

Acute renal failure

774

1088

7.63

307.65

2.0

1.2

—

L04AA Selective immunosuppressants

1671

1658

11.80

307.65

2.5

1.2

—

Other dialysis

512

221

41.71

307.65

2.8

1.4

—

Oral corticosteroids

2388

5671

2.55

307.65

1.4

1.5

—

Transplanted organ and tissue status

1891

606

56.79

307.65

2.6

1.2

—

Kidney transplant status

1114

377

63.60

307.65

3.2

1.3

—

Secondary uncertain malignant neoplasm

471

654

7.75

307.65

1.3

1.4

—

All kidney diseases

2704

5835

3.27

307.65

2.1

1.2

—

Bacterial infection, other or unspecified

1899

3151

5.35

307.65

1.8

1.3

—

Persons encountering health services for specific procedures and health care

3074

5519

3.45

307.65

1.9

1.2

—

Certain infectious and parasitic diseases

2133

3785

2.88

307.65

1.6

1.3

—

Dialysis, with operation codes

1698

742

32.95

307.65

2.6

1.2

—

Anaemias

988

971

7.07

307.65

2.0

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

672

647

11.64

307.65

1.4

—

Implicit viral Sepsis

704

1191

6.29

307.65

2.1

1.3

—

Aplastic and other anaemias

1192

2774

4.16

307.65

1.8

1.4

—

Other and unspecified anaemias

990

2574

3.79

306.76

1.7

1.4

—

Other anaemias

995

2594

3.77

305.72

1.7

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

2263

6295

2.47

305.69

1.7

1.4

—

Glomerulonephritis

472

708

7.39

304.84

2.8

1.5

—

All pneumoniae

2281

6443

2.42

294.86

1.7

1.4

—

Polycystic kidney disease

260

192

17.99

290.93

2.7

1.4

—

Autoimmune diseases excluding thyroid diseases

2385

5519

2.41

289.13

1.6

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

496

820

6.46

288.91

1.3

1.5

—

Pneumonia, organism unspecified

2008

5701

2.52

287.87

1.7

1.4

—

Heart failure and antihypertensive medication

711

926

5.25

287.04

2.0

1.2

—

Diabetic nephropathy

575

1092

5.62

285.14

2.6

1.4

—

Diabetic nephropathy, excluding more controls

572

847

6.02

284.98

2.6

1.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

2326

5383

2.41

284.42

1.6

1.4

—

Malaise and fatigue

1070

2524

3.50

283.04

1.4

—

Other viral diseases

999

2937

3.56

280.65

1.9

1.5

—

Covid-19 confirmed case

959

2820

3.53

269.51

1.8

1.4

—

Diffuse large B-cell lymphoma

260

212

14.26

269.45

1.4

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

260

212

14.26

269.45

1.4

1.3

—

Diffuse large B-cell lymphoma, including Hilmo

260

212

14.26

269.45

1.4

1.3

—

Non-Hodgkin lymphoma, all

240

171

16.16

268.68

1.4

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2163

6401

2.35

265.07

1.7

1.4

—

Congenital malformations of the urinary system

365

488

8.67

263.89

2.7

1.6

—

Agranulocytosis

444

737

6.55

258.92

1.6

1.4

—

Other viral diseases

1148

3832

3.09

258.04

1.9

1.4

—

Congenital malformations of the urinary system

369

519

8.16

254.76

2.7

1.6

—

Hypertensive diseases

1689

3666

2.66

252.69

2.1

1.2

—

Multiple myeloma, including Hilmo

237

184

14.77

252.41

1.6

1.3

—

Hypertension

1687

3663

2.66

252.10

2.1

1.2

—

Other heart diseases

1157

2457

3.16

244.23

1.9

1.2

—

Other disorders involving the immune mechanism, not elsewhere classified

259

252

12.84

242.15

2.6

1.5

—

Acute peritonitis

308

372

9.26

240.51

2.7

1.4

—

Heart failure,strict

1004

2176

3.34

237.68

1.8

1.2

—

Other medical care

922

2531

3.36

236.45

1.4

1.2

—

Myeloid leukaemia

213

158

16.83

235.81

1.4

—

Other diseases of liver

561

1247

4.76

234.34

1.3

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

1588

3571

2.62

231.73

1.9

1.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

247

240

12.95

231.41

2.7

1.5

—

Provisional assignment of new diseases of uncertain etiology

1255

4756

2.71

224.05

1.7

1.4

—

Codes for special purposes

1256

4766

2.70

223.65

1.7

1.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

363

338

8.05

222.12

1.4

1.3

—

Intestinal infectious diseases

2000

7060

2.19

212.95

1.8

1.4

—

Certain disorders involving the immune mechanism

591

1480

4.21

211.45

2.0

1.4

—

Acute myeloid leukaemia and myelodysplastic syndromes

152

26.70

211.09

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

472

996

5.04

210.59

1.4

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

236

243

11.03

208.74

1.6

1.4

—

Chronic nephritic syndrome

234

240

11.35

208.44

2.9

1.3

—

Anaemia in chronic diseases classified elsewhere

183

129

17.60

208.26

2.6

1.5

—

Any reimbursement code in KELA

1300

2363

2.81

208.19

1.6

1.2

—

Metabolic disorders

1874

5118

2.27

207.69

1.8

1.4

—

Autoimmune diseases

2289

5555

2.13

206.41

1.6

1.4

—

Lung transplantation

142

44.27

205.72

1.6

1.5

—

Hyperparathyroidism

464

967

4.96

205.29

2.5

1.3

—

Lung transplant status

141

44.67

204.93

1.6

1.5

—

Multiple myeloma

161

21.15

204.68

1.6

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

161

21.15

204.68

1.6

1.2

—

ILD, hospital admission 2, with pulmonary infections

301

425

7.55

203.73

1.4

1.3

—

Other inflammatory liver diseases

291

402

8.00

202.49

1.2

1.5

—

Coagulation defects, purpura and other haemorrhagic conditions

589

1522

4.07

201.60

1.6

1.4

—

Disorders of parathyroid gland

501

1133

4.55

200.00

2.4

1.3

—

Lymphoid leukaemia

273

360

8.54

198.60

1.2

1.5

—

Used for control exclusion in common control thyroid runs

2179

5238

2.14

197.57

1.6

1.4

—

IgA nephropathy (IgA glomerulonephritis)

197

175

14.15

195.83

2.9

1.4

—

Fibrosis and cirrhosis of liver

296

436

7.41

193.92

1.5

1.4

—

Cardiovascular diseases

1500

3320

2.48

193.22

1.9

1.2

—

Purpura and other haemorrhagic conditions

448

973

4.90

193.11

1.5

—

Hypertension, essential

1475

3452

2.46

190.85

1.9

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1532

6123

2.30

190.04

1.9

1.4

—

Abnormal findings on examination of blood, without diagnosis

1013

3420

2.80

189.04

1.5

—

Gout, FINNGEN

620

1722

3.71

189.00

1.9

1.4

—

Examination and observation for other reasons

1235

2735

2.66

187.88

1.6

1.3

—

Gout

620

1491

3.78

187.71

1.9

1.4

—

Hernia of abdominal wall, postoperative

337

583

5.96

185.82

2.0

1.2

—

Certain infectious and parasitic diseases

1358

2712

2.55

181.72

1.5

1.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

156

104

17.43

181.31

1.1

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

156

104

17.43

181.31

1.1

1.3

—

Chronic lymphocytic leukaemia

156

104

17.43

181.31

1.1

1.3

—

Nephrotic syndrome

214

240

10.65

179.38

3.3

1.6

—

Autoimmune diseases related-to ILD

1700

6871

2.15

178.49

1.4

1.5

—

Malignant neoplasm

1618

4291

2.27

177.35

1.5

—

Acute upper respiratory infections of multiple and unspecified sites

1593

5392

2.23

176.85

1.6

1.4

—

COPD/asthma/ILD related infections

1930

4581

2.14

176.10

1.5

1.4

—

COPD/asthma related infections

1930

4581

2.14

176.10

1.5

1.4

—

Diseases of peritoneum

340

633

5.74

175.28

2.6

1.4

—

Bronchitis

2081

6605

2.01

171.86

1.6

1.4

—

Other respiratory diseases principally affecting the interstitium

437

1017

4.49

171.71

1.5

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP)

310

543

6.24

171.59

1.2

1.3

—

Thrombocytopenia, unspecified

283

455

6.78

170.66

1.4

—

Nausea and vomiting

647

1943

3.37

169.18

1.9

1.4

—

Malignant neoplasm, wide definition for exclusion

1658

4488

2.20

169.05

1.5

—

Percutaneous Coronary Intervention

1439

3855

2.33

168.95

1.8

1.5

—

Coronary revascularization (ANGIO or CABG)

1436

3856

2.32

167.20

1.8

1.5

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

310

560

6.05

166.13

1.2

1.3

—

Heart failure, strict

1030

2797

2.65

164.30

1.8

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1196

4545

2.40

164.00

1.5

—

ILD, hospital admissions 3, with pneumonia sepsis

253

375

7.19

163.90

1.3

1.4

—

Acute myeloid leukaemia, including Hilmo

107

37.68

163.56

1.4

1.6

—

Acute myeloid leukaemia

107

37.68

163.56

1.4

1.6

—

Acute myeloid leukaemia, helper endpoint

107

37.68

163.56

1.4

1.6

—

Headache

1167

3876

2.44

163.16

1.5

1.4

—

Care involving use of rehabilitation procedures

1116

4243

2.46

163.09

1.8

1.2

—

Gastrointestinal diseases

1195

2379

2.56

161.28

1.5

1.3

—

Cirrhosis of liver, NAS

228

311

8.13

160.70

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

1960

6572

2.00

159.49

1.7

1.4

—

Emergency coronary revascularization (for ACS)

1492

4123

2.24

159.42

1.8

1.4

—

Cholangitis (primary sclerosing, PSC)

245

370

7.21

156.83

1.6

1.5

—

Other interstitial pulmonary diseases

377

843

4.68

156.06

1.4

—

Hepatic failure, not elsewhere classified

183

198

10.44

156.02

1.4

1.5

—

Interstitial lung disease

377

845

4.67

155.60

1.4

—

Interstitial lung disease endpoints

377

845

4.67

155.60

1.4

—

Ischemic heart diseases

1475

4050

2.22

155.02

1.8

1.4

—

Oxycodone

728

2251

3.00

154.68

1.6

1.4

—

ILD, hospital admissions

374

839

4.67

154.24

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

322

642

5.40

154.21

1.3

—

Other heart diseases, wide

1829

5605

2.03

152.58

1.7

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

322

650

5.33

152.04

1.3

—

Major coronary heart disease event

1468

4078

2.21

151.98

1.8

1.4

—

Other disorders of fluid, electrolyte and acid-base balance

610

1831

3.26

151.12

2.0

1.3

—

Medical observation and evaluation for suspected diseases and conditions

1268

2748

2.40

150.98

1.6

1.3

—

Acute tubulo-interstitial nephritis

1118

4115

2.39

150.55

1.9

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

490

873

4.00

148.94

2.3

1.2

—

Rare circulating lymphoid malignancy, including Hilmo

178

199

10.41

148.85

1.4

1.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2082

5924

1.94

148.78

1.7

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

1241

2746

2.40

148.56

1.7

1.3

—

ILD, hospital admissions 1, main diag only

348

760

4.81

148.55

1.4

—

Persons encountering health services in other circumstances, wide

2176

5932

1.91

148.21

1.7

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

537

1552

3.53

147.81

2.5

1.6

—

All influenza

586

1843

3.28

147.79

1.9

1.5

—

Hard cardiovascular diseases

1484

4138

2.17

147.36

1.8

1.4

—

All-cause Heart Failure

976

2732

2.57

146.81

1.8

1.4

—

Antihypertensive medication - note that there are other indications

1412

3391

2.25

146.79

1.9

1.3

—

Oedema, not elsewhere classified

549

1646

3.37

145.30

1.6

1.4

—

Heart failure and coronary heart disease

749

1856

2.93

143.31

1.8

1.3

—

Insulin, fast-acting

813

3110

2.69

143.20

2.1

1.4

—

Any death

1086

3296

2.41

142.54

1.5

1.4

—

Ascites

238

384

6.62

142.37

1.5

1.4

—

Disorders of other endocrine glands

949

3878

2.47

139.96

2.1

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

543

1640

3.37

139.54

2.5

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1169

4844

2.25

138.22

2.0

1.4

—

Dependence on enabling machines and devices, not elsewhere classified

118

19.53

136.94

4.2

1.1

—

Intestinal infectious diseases

2104

6539

1.86

135.55

1.6

1.4

—

Insulin, fast-acting or short human

815

3212

2.60

135.04

2.1

1.4

—

Hypertensive Renal Disease

147

144

11.17

133.87

2.5

1.2

—

Other pulmonary diagnosis

1428

3362

2.16

133.23

1.5

1.4

—

Any event in cancer register

1687

5066

1.99

132.84

1.5

—

Complications of surgical and medical care, not elsewhere classified

1795

6482

1.92

132.77

1.8

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

692

1132

3.12

132.37

1.5

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

841

2026

2.67

132.37

1.7

1.2

—

Tramadol

1407

4142

2.12

132.32

1.6

1.4

—

Endocrine, nutritional and metabolic diseases

1631

4112

2.04

131.83

1.7

1.3

—

2014

5590

1.88

131.50

1.5

1.4

—

Systemic connective tissue disorders

682

2493

2.81

131.37

1.4

—

Excluding asthma or asthma-COPD overlap

1421

3362

2.15

130.99

1.5

1.4

—

389

1018

4.00

130.84

1.7

1.3

—

Implicit fungal Sepsis

212

332

6.83

130.63

1.9

1.3

—

Insulin medication

1169

4537

2.21

130.32

2.0

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1220

2748

2.28

130.10

1.6

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

171

216

8.76

128.63

1.3

—

COPD differential diagnosis

1410

3356

2.13

128.06

1.5

1.4

—

ILD differential diagnosis

1409

3356

2.13

127.73

1.5

1.4

—

Polyarthropathies

1343

4228

2.11

126.64

1.7

1.5

—

Complications of medical and surgical care

1316

5946

2.07

126.41

1.8

1.4

—

Idiopathic pulmonary fibrosis

216

357

6.43

126.03

1.3

—

Fungal Sepsis

164

204

8.85

124.82

1.9

1.3

—

Noninfective enteritis and colitis

977

4328

2.30

124.33

1.5

—

Genitourinary diseases

1228

2817

2.22

122.65

1.9

1.2

—

Oesophageal varices

182

262

7.72

122.44

1.5

—

Acute upper respiratory infections

1845

6165

1.87

122.20

1.5

1.4

—

Viral pneumonia

335

827

4.23

122.03

1.8

1.4

—

Bleeding

1421

5109

2.01

119.92

1.8

1.4

—

Atrial fibrillation and flutter

548

1131

3.21

119.60

1.7

1.2

—

Erysipelas

840

3104

2.43

119.18

1.8

1.3

—

Neoplasms

1577

4290

1.98

118.78

1.6

1.4

—

Symptoms and signs involving the digestive system and abdomen

1836

4949

1.88

118.54

1.6

1.5

—

Implicit fungal Sepsis

154

190

8.95

118.08

1.9

1.3

—

Hyperkalaemia

177

255

7.42

117.91

2.5

1.3

—

Opioids

1799

5033

1.88

116.84

1.4

—

Other viral diseases, not elsewhere classified

503

1662

3.14

116.75

2.0

1.5

—

Follicular lymphoma, hilmo

165

228

7.97

114.92

1.3

—

Viral infections characterized by skin and mucous membrane lesions

869

3800

2.34

114.33

1.8

1.5

—

Chronic hepatitis, not elsewhere classified

153

196

8.69

113.96

1.2

1.4

—

Other disorders of skin and subcutaneous tissue

1175

5130

2.07

112.26

1.8

1.4

—

Insulin, intermediate and long-acting

987

4476

2.18

110.03

1.9

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1057

5016

2.11

109.25

1.8

1.4

—

Erysipelas

1059

3811

2.15

109.24

1.7

1.3

—

Other disorders of white blood cells

194

337

6.23

108.19

1.4

—

Other viral diseases, not elsewhere classified

652

2562

2.61

107.92

1.8

1.5

—

Other bacterial intestinal infections

389

1166

3.45

106.36

1.7

1.4

—

Type 2 diabetes, wide definition

1281

4134

2.01

106.35

1.8

1.4

—

Drug-induced neutropenia

225

460

5.23

104.69

1.5

1.4

—

Alcoholic liver disease

265

617

4.52

104.63

1.2

1.5

—

Maternal care for other conditions predominantly related to pregnancy

514

1793

2.90

104.38

1.3

—

Abnormal findings on diagnostic imaging of lung

764

3141

2.37

104.12

1.5

1.4

—

Disorders of lens

1118

3382

2.10

102.82

1.9

1.4

—

Budesonide

350

1004

3.62

102.78

1.3

1.4

—

Pneumocystosis

114

116

11.68

102.59

1.5

1.4

—

Type 1 diabetes

599

2330

2.64

102.13

2.3

1.4

—

Myelodysplastic syndrome, including Hilmo

108

101

11.71

101.56

1.4

1.3

—

Ulcer of lower limb, not elsewhere classified

306

809

3.93

101.23

2.2

1.4

—

Asthma, excluding more controls

1213

3123

2.05

101.07

1.5

1.4

—

Haemolytic anaemias

154

229

7.46

100.61

1.7

1.5

—

Factors influencing health status and contact with health services

485

754

3.28

100.53

1.6

1.1

—

Reimbursement for rheumatic diseases

1007

4897

2.08

100.11

1.4

1.5

—

Abnormal serum enzyme levels

575

2159

2.66

99.58

1.4

1.5

—

Cerebrovascular diseases (FINNGEN)

519

1284

2.92

99.35

1.7

1.2

—

Abnormalities of breathing

1643

5320

1.82

98.66

1.5

—

Leukaemia of unspecified cell type

19.64

98.17

1.3

—

Diabetic maculopathy, excluding more controls

286

742

4.03

97.52

2.5

1.3

—

Acquired haemolytic anaemia

120

139

9.80

97.32

1.7

1.4

—

Bacterial intestinal infections, IBD co-morbidities

386

1218

3.27

97.14

1.7

1.4

—

Cardiomyopathy

357

1074

3.43

97.04

1.7

1.4

—

Hypoplasia of dental enamel

117

141

12.53

96.02

4.2

1.9

—

Diabetic retinopathy, strict definition

417

1209

3.18

95.80

2.4

1.5

—

Viral infections characterized by skin and mucous membrane lesions

1544

7488

1.79

94.55

1.6

1.5

—

Need for immunization against other single viral diseases

114

130

10.22

94.05

3.1

1.5

—

Hypertensive heart and/or renal disease

420

1010

3.17

94.03

2.3

1.2

—

Bacterial pneumonia (organism specified)

771

3138

2.27

93.55

1.7

1.4

—

Pain, not elsewhere classified

472

1702

2.83

93.25

1.5

1.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

119

147

9.54

92.42

1.7

1.6

—

Inflammatory bowel disease

685

2974

2.36

92.16

1.4

1.5

—

Bacterial pneumoniae

672

2517

2.40

92.08

1.8

1.4

—

Asthma

1232

3332

1.96

91.17

1.5

1.4

—

Autoimmune hepatitis

21.02

91.16

1.2

1.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1237

4020

1.93

90.88

1.7

1.4

—

Mantle cell lymphoma, including Hilmo

15.79

90.79

1.4

1.3

—

Gout, idiopatic and unspecified

441

1559

2.90

90.78

2.0

1.4

—

Asthma, unspecified (mode), excluding more controls

813

2778

2.22

90.57

1.5

1.4

—

Diseases of oesophagus, stomach and duodenum

1802

6340

1.72

90.46

1.6

1.4

—

Vitreous haemorrhage

257

653

4.13

90.33

2.5

1.4

—

Other acute lower respiratory infections

979

4672

2.03

90.16

1.7

1.5

—

Gingival hyperplasia

161

281

6.37

90.10

3.4

1.5

—

Other and unspecified disorders of white blood cells

147

234

6.83

89.66

1.3

1.4

—

Abdominal and pelvic pain

1712

4946

1.76

89.29

1.6

1.5

—

Other bacterial intestinal infections

448

1612

2.85

89.23

1.7

1.3

—

Atrial fibrillation and flutter with reimbursement

402

803

3.25

89.21

1.5

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1822

5349

1.73

89.03

1.5

—

Osteopathies and chondropathies

942

4354

2.05

88.63

1.7

1.4

—

5-aminosalicylic acid

464

1712

2.79

88.19

1.3

1.5

—

Bacterial pneumonia, not elsewhere classified

637

2373

2.41

88.15

1.7

1.4

—

Hypothyroidism (congenital or acquired)

520

1059

2.83

88.12

1.5

1.2

—

Enterocolitis due to Clostridium difficile

246

616

4.16

87.97

1.8

1.3

—

Gout, unspecified

369

1202

3.16

87.96

1.9

1.4

—

Other diseases of pleura

703

2723

2.30

87.95

1.6

1.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

128

180

7.77

87.69

1.5

1.4

—

Type 1 diabetes, wide definition, subgroup 1

499

1920

2.67

87.26

2.3

1.4

—

Streptococcal septicaemia

207

458

4.72

87.03

1.7

1.4

—

Non-ischemic cardiomyopathy

499

1510

2.72

86.69

1.8

1.4

—

Mantle cell lymphoma

24.52

86.65

1.4

1.2

—

Type 1 diabetes, wide definition

517

2032

2.61

86.49

2.3

1.4

—

IBD patients in KELA-register

541

2181

2.55

86.10

1.3

1.5

—

Infections of the skin and subcutaneous tissue

1108

5841

1.91

85.90

1.8

1.5

—

Diseases of the skin and subcutaneous tissue

1722

5047

1.73

84.99

1.6

1.4

—

Explicit bacterial Sepsis

241

614

4.08

84.12

1.7

1.3

—

Dyspnoea

1474

6260

1.76

84.05

1.5

—

Diabetic retinopathy, excluding more controls

523

1094

2.76

83.69

2.2

1.4

—

Molar incisor enamel hypoplasia, with caries

108

12.78

83.61

4.1

1.6

—

Hypothyroidism, levothyroxine purchases

507

1050

2.78

83.55

1.5

1.2

—

Hypothyroidism and >3 levothyroxin purchases

507

1050

2.78

83.55

1.5

1.2

—

Asthma (only as main-diagnosis), excluding more controls

1070

3123

1.98

83.51

1.5

1.4

—

Sub-endpoint used in defining T1D endpoints

608

2574

2.38

83.13

2.3

1.5

—

Inflammatory bowel disease, strict (require KELA)

541

2219

2.51

82.99

1.3

1.5

—

Disorders of gallbladder, biliary tract and pancreas

1577

5804

1.73

82.44

1.5

1.4

—

Gout, strict definition

331

1059

3.22

81.46

2.0

1.4

—

Amputation

217

524

4.30

81.43

2.5

1.3

—

Other necrotizing vasculopathies

182

384

4.99

81.33

1.8

1.4

—

Heart failure and bmi 25plus

545

1461

2.57

81.26

1.7

1.4

—

Asthma, unspecified (mode)

818

2957

2.11

80.55

1.5

1.4

—

Cardiomyopathies, Primary/intrinsic

255

697

3.79

80.48

1.7

1.4

—

Non-invasive ventilation

440

1458

2.75

80.40

1.8

1.3

—

Other infectious diseases

200

460

4.57

80.31

1.9

1.4

—

Drug-induced cataract

112

153

8.26

79.29

2.5

1.5

—

Cardiomyopathy (excluding other)

260

729

3.69

79.01

1.7

1.4

—

Other infectious diseases

226

577

4.10

78.92

1.8

1.4

—

Unspecified jaundice

143

251

6.03

78.56

1.6

1.4

—

Asthma (mode)

1170

3356

1.89

78.05

1.4

—

Persons encountering health services for examination and investigation

1062

2748

1.96

77.69

1.5

1.3

—

Other diseases of biliary tract

200

474

4.40

77.11

1.6

1.4

—

Protozoal diseases

125

198

7.00

77.04

1.5

1.4

—

Other reaction to severe stress, and adjustment disorders

749

3621

2.11

77.02

1.7

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

1136

5995

1.83

77.00

1.9

1.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

146

269

5.88

76.72

2.8

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

1170

6414

1.81

76.63

1.5

—

ILD-related respiratory insufficiency

111

155

7.79

76.48

1.4

—

Nutritional anaemias

767

3606

2.08

76.15

1.7

1.4

—

Solid cancers, helper endpoint

1261

4152

1.81

75.96

1.5

—

Diseases of the digestive system

754

3652

2.09

75.80

1.7

1.4

—

Asthma (only as main-diagnosis)

1082

3332

1.90

75.15

1.5

1.4

—

Parasetamol

1390

4015

1.77

75.07

1.5

1.4

—

Codeine

1532

4908

1.71

74.75

1.4

—

Neurotic, stress-related and somatoform disorders

1561

6573

1.68

74.62

1.5

—

Anxiety disorders, excluding more controls

1439

5492

1.72

74.56

1.5

—

Peripheral artery operations in Hilmo

236

644

3.77

74.48

2.4

1.3

—

Other retinal disorders

953

3889

1.93

74.22

2.0

1.4

—

Ulcerative colitis

524

2234

2.40

73.71

1.3

1.5

—

Insulin, fast-acting (human)

347

1210

2.97

73.71

2.5

1.4

—

Other diseases of intestines

1844

6534

1.62

73.66

1.6

1.5

—

Anxiety disorders

1568

6607

1.67

73.57

1.5

—

Iron deficiency anaemia

677

3151

2.15

73.56

1.7

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

147

282

5.46

73.19

1.3

—

Colitis, primary sclerosing

108

9.95

73.02

1.5

—

Hodgkin lymphoma, hilmo

126

213

6.55

72.83

1.4

—

Cardiac arrhythmias

1034

3599

1.89

72.50

1.6

1.4

—

Finngen Rheumatological endpoints

1654

5730

1.66

72.31

1.5

—

Postviral fatigue syndrome

14.60

72.08

1.3

1.6

—

ILD medications: pirfenidone

20.22

71.98

1.4

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1200

6342

1.77

71.96

1.8

1.4

—

Other diseases of pericardium

131

231

6.03

71.76

1.7

1.3

—

Other diseases of the digestive system

523

2250

2.37

71.71

1.7

1.4

—

Polyneuropathies and other disorders of the peripheral nervous system

392

1476

2.73

71.71

1.8

1.4

—

Syncope and collapse

606

2342

2.24

71.61

1.4

—

Complications of procedures, not elsewhere classified

1272

6111

1.74

71.57

1.8

1.4

—

Chronic tubulo-interstitial nephritis

111

166

7.12

71.50

2.2

1.2

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

173

389

4.64

71.36

1.4

1.3

—

Acute bronchitis

694

3285

2.10

71.17

1.7

1.4

—

Diseases of arteries, arterioles and capillaries

969

3810

1.90

71.13

2.0

1.4

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

237

678

3.65

70.25

1.9

1.4

—

Amputation of toe

169

382

4.64

69.40

2.5

1.4

—

Toxic liver disease

11.09

69.30

1.6

1.3

—

Dermatitis and eczema

1837

7233

1.59

68.96

1.5

—

Coronary atherosclerosis

892

2923

1.95

68.70

1.8

1.4

—

GI-bleeding

514

2236

2.34

68.68

1.7

1.4

—

Idiopathic thrombocytopenic purpura

118

198

6.52

68.53

1.4

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

486

2065

2.40

68.53

1.6

1.4

—

Nonalcoholic fatty liver disease

248

743

3.49

68.51

1.3

1.5

—

Cardiomyopathy, other and unspecified

179

427

4.37

68.49

1.6

1.4

—

Gout due to impairment of renal function

14.88

68.38

2.4

1.4

—

Hepatocellular carcinoma, including Hilmo

118

8.41

68.09

1.3

—

Valvular heart disease excluding rheumatic fever

699

2428

2.11

68.05

1.8

1.4

—

ILD medications: nintedanib

33.19

67.99

1.4

1.2

—

Venous thromboembolism

780

3853

1.98

67.86

1.6

1.4

—

6-mercaptopurine

135

261

5.60

67.33

1.2

1.4

—

Non-rheumatic valve diseases

685

2378

2.11

66.66

1.8

1.4

—

Other cataract

664

2401

2.12

66.55

2.0

1.4

—

Other and unspecified aplastic anaemias

14.32

66.47

1.5

1.4

—

Disorders of choroid and retina

1184

4855

1.75

66.25

1.9

1.4

—

Other and unspecified polyneuropathies, also in other diseases

339

1237

2.81

65.99

1.8

1.4

—

Disorders of mineral metabolism

196

516

3.96

65.61

1.9

1.4

—

Mucosal proctocolitis

320

1140

2.91

65.55

1.3

1.5

—

Zoster [herpes zoster]

325

1164

2.87

65.50

1.5

1.4

—

Senile cataract

882

2841

1.93

64.60

1.8

1.4

—

Hyperlipidaemia, other/unspecified

538

2248

2.24

63.86

1.8

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

107

8.52

63.82

1.4

—

Dermatitis

984

5525

1.80

63.52

1.6

1.4

—

Adjustment and management of implanted device

258

826

3.19

63.29

1.5

1.2

—

Abnormal results of function studies

222

653

3.55

63.15

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

877

4781

1.86

62.96

1.8

1.4

—

Other necrotizing vasculopathies (FG)

139

292

4.99

62.44

1.8

1.4

—

Other CVD (FINNGEN)

190

375

4.03

61.28

1.7

1.2

—

Other systemic involvement of connective tissue (FG)

409

1670

2.46

61.19

1.2

1.4

—

Zoster [herpes zoster]

718

3652

1.96

60.92

1.4

—

Ulcerative colitis, NAS

324

1207

2.77

60.90

1.4

1.5

—

Other and unspecified dermatitis

841

4585

1.86

60.72

1.6

1.4

—

IBD (strict) with PSC

11.35

60.53

1.4

1.5

—

Diabetes, varying definitions

1635

6097

1.59

60.45

1.8

1.4

—

Presence of cardiac and vascular implants and grafts

550

1887

2.19

59.84

1.6

1.1

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

108

188

6.04

59.81

1.5

1.3

—

Diabetic retinopathy

585

1705

2.19

59.69

2.2

1.5

—

Other noninfective gastroenteritis and colitis

463

2050

2.31

59.54

1.6

1.5

—

Depression medications

528

1156

2.33

59.43

1.4

1.2

—

Hypo-osmolality and hyponatraemia

269

912

3.00

59.18

2.0

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

114

211

5.67

59.16

1.4

1.3

—

Diabetes mellitus

1638

6126

1.58

59.03

1.8

1.4

—

Other autoimmune haemolytic anaemias

12.25

58.75

1.4

—

Acute sinusitis

884

4562

1.82

58.60

1.6

1.4

—

SLE (Finngen)

102

172

6.32

58.59

1.3

1.4

—

Pure hypercholesterolaemia

988

3641

1.79

58.57

1.6

1.4

—

Mycoses

475

2148

2.26

58.18

1.8

1.4

—

Mature T/NK-cell lymphomas, hilmo

10.52

57.95

1.6

1.4

—

Paroxysmal tachycardia

360

1187

2.58

57.66

1.6

1.2

—

Pain (limb, back, neck, head abdominally)

1212

3592

1.71

57.48

1.5

—

Other soft tissue disorders, not elsewhere classified

1573

5890

1.58

57.16

1.5

—

Hepatocellular carcinoma

9.70

57.10

1.3

—

Ulcerative colitis (strict definition, require KELA)

371

1529

2.50

56.59

1.3

1.5

—

L01XE Protein kinase inhibitors

140

322

4.60

56.52

1.3

—

Diseases of the respiratory system

999

2815

1.80

56.44

1.5

1.4

—

Statin medication

1113

3667

1.72

56.25

1.8

1.3

—

Diseases of the eye and adnexa

1468

4602

1.61

56.17

1.6

1.4

—

Cutaneous abscess, furuncle and carbuncle

499

2344

2.17

55.63

1.8

1.4

—

Colitis, primary sclerosing, strict definition

10.14

55.47

1.4

1.5

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

362

1493

2.50

55.17

1.3

1.5

—

Other and unspecified iron deficiency

514

2446

2.13

55.06

1.6

1.4

—

Gingivitis and periodontal diseases

1568

5177

1.58

54.97

1.6

1.4

—

Other systemic involvement of connective tissue

424

1874

2.30

54.79

1.2

1.4

—

Other skin changes

313

1208

2.65

54.63

1.6

1.4

—

Personal history of other diseases and conditions

272

975

2.87

54.62

1.7

1.2

—

Molar incisor enamel hypoplasia

163

417

4.12

54.53

3.6

1.6

—

Crohn disease

306

1174

2.69

54.36

1.4

1.5

—

Viral hepatitis, IBD co-morbidity

141

335

4.38

54.30

1.2

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

385

1644

2.40

54.25

1.3

1.5

—

Osteomyelitis

162

429

3.96

54.01

2.2

1.5

—

Mood disorders, excluding more controls

1496

5719

1.58

54.00

1.5

1.4

—

Marginal zone B-cell lymphoma, including Hilmo

10.57

53.98

1.5

1.3

—

Neurological diseases, wide definition

603

1455

2.11

53.85

1.5

1.4

—

Type 2 diabetes

1477

5508

1.58

53.80

1.7

1.4

—

Myelodysplastic syndrome

17.17

53.67

1.4

1.1

—

Depression

1572

6949

1.55

53.63

1.5

—

Other or ill-defined heart diseases

138

327

4.41

53.40

1.8

1.5

—

Diabetic maculopathy

275

947

2.84

53.14

2.5

1.5

—

Asthma, hospital admissions 3, pneumonia

564

2810

2.03

53.14

1.6

1.5

—

Asthma-related pneumonia or sepsis

564

2810

2.03

53.14

1.6

1.5

—

Cough

648

3201

1.94

53.09

1.6

1.4

—

Ischaemic heart disease, wide definition

1051

3840

1.71

53.02

1.7

1.4

—

Symptoms and signs concerning food and fluid intake

184

534

3.54

52.98

2.0

1.4

—

Osteoporosis

356

1374

2.46

52.94

1.6

1.3

—

All influenza (not pneumonia)

292

1107

2.71

52.88

1.9

1.4

—

Asthma-related pneumonia

562

2802

2.03

52.86

1.6

1.5

—

Asthma, hospital admission 2, infections

956

5511

1.72

52.83

1.6

1.5

—

Asthma-related infections

956

5511

1.72

52.83

1.6

1.5

—

Pulmonary embolism

422

1892

2.27

52.62

1.5

1.4

—

Peripheral artery disease

562

2204

2.06

52.57

2.1

1.3

—

Pericarditis

180

5.82

52.54

1.8

1.4

—

Other diseases of the respiratory system

314

1237

2.59

52.44

1.7

1.4

—

Other respiratory disorders and diseases

314

1237

2.59

52.44

1.7

1.4

—

Pulmonary heart disease

422

1898

2.26

52.23

1.5

1.4

—

Periodontitis

1426

6122

1.57

52.10

1.7

1.4

—

Disorders of calcium metabolism

146

368

4.14

52.06

2.1

1.4

—

Hypoplasia of dental enamel , including avohilmo

154

396

4.14

51.86

3.5

1.7

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

12.58

51.65

2.1

1.3

—

Chronic periodontitis, including avohilmo

1420

6121

1.57

51.49

1.7

1.4

—

Immunodeficiency with predominantly antibody defects

178

5.93

51.38

1.7

1.5

—

Chronic gastritis

376

1625

2.35

51.16

1.5

1.4

—

Respiratory insufficiency

134

319

4.31

51.03

1.7

1.3

—

Immunodeficiencies

138

341

4.29

50.85

1.7

1.5

—

Endocarditis

179

5.74

50.69

1.8

1.3

—

Arthropathies in other diseases classified elsewhere

105

209

5.34

50.52

2.5

1.5

—

Systemic lupus erythematosus

102

198

5.48

50.50

1.3

1.5

—

Dilated cardiomyopathy

229

785

3.01

50.36

1.6

1.5

—

Mood disorders

1643

7095

1.51

49.97

1.5

—

Maternal care for known or suspected fetal abnormality and damage

338

1199

2.49

49.90

1.3

1.4

—

Codeine or tramadol medication

1765

6498

1.50

49.88

1.4

—

Mood [affective] disorders

1640

7096

1.51

49.82

1.5

—

Continuous positive airway pressure

302

992

2.61

49.59

1.8

1.4

—

Haemorrhage, not elsewhere classified

151

6.11

49.49

1.9

1.3

—

Pain in throat and chest

1312

5002

1.59

49.28

1.5

1.4

—

Early onset COPD, excluding more controls

287

1116

2.62

49.11

1.5

1.4

—

Noninfectious colitis NAS

277

1063

2.68

49.11

1.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1399

5438

1.56

49.03

1.8

1.4

—

Other gastritis (incl. Duodenitis)

344

1460

2.40

48.92

1.5

1.4

—

DVT of lower extremities and pulmonary embolism

571

2934

1.96

48.89

1.6

1.4

—

Myocarditis

111

238

4.86

48.63

1.4

1.2

—

Viral pneumonia (unknown virus, not influenza)

171

507

3.52

48.18

1.7

1.5

—

Haemorrhage from respiratory passages

491

2164

2.07

48.15

1.6

1.4

—

Viral pneumonia (known virus, not influenza)

175

5.76

47.93

2.0

1.5

—

Cerebral cysts

153

425

3.77

47.68

1.6

1.5

—

Pain in joint

920

3470

1.71

46.34

1.4

1.5

—

Persons with potential health hazards related to communicable diseases

758

4313

1.77

46.34

1.8

1.5

—

Anxiety (asthma-related co-morbidities)

1051

5029

1.63

46.32

1.4

1.5

—

Charcot foot

103

7.47

46.22

2.8

1.3

—

SLE, strict definition

192

5.31

45.98

1.3

1.4

—

SLE, ICD10

192

5.31

45.98

1.3

1.4

—

Chronic periodontitis, complicated

773

4432

1.75

45.72

1.8

1.4

—

All anxiety disorders

1074

5300

1.62

45.71

1.4

1.5

—

Diagnoses used for exclusion with ILD

383

1758

2.22

45.25

1.4

—

Presence of other functional implants

649

2437

1.86

44.81

1.7

1.1

—

Other metabolic disorders

246

932

2.71

44.73

1.6

1.4

—

Other Crohn's disease

178

567

3.27

44.73

1.3

1.5

—

751

4312

1.75

44.44

1.6

1.5

—

Symptoms and signs involving the urinary system

1087

5213

1.60

44.37

1.7

1.4

—

Other pleural conditions

173

542

3.28

44.35

1.6

1.4

—

Primary biliary cholangitis (PBC)

8.32

44.34

1.4

—

Persons encountering health services for specific procedures, not carried out

177

565

3.24

44.12

1.5

1.2

—

Diseases of oral cavity, salivary glands and jaws

802

2346

1.77

44.08

1.5

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

1457

5888

1.51

43.31

1.8

1.4

—

Isolated proteinuria

204

5.07

43.06

2.6

1.4

—

Unspecified nephritic syndrome

132

6.23

42.62

3.0

1.3

—

Pacemaker

398

1822

2.12

42.05

1.5

1.4

—

Chronic apical periodontitis

1710

6750

1.45

42.05

1.6

1.4

—

Hydronephrosis

186

629

3.03

41.84

2.2

1.2

—

Other arthritis (FG)

474

2429

1.98

41.65

1.5

1.4

—

Congenital malformations of gallbladder, bile ducts and liver

8.22

41.22

2.7

1.8

—

STROKE

713

2772

1.77

41.08

1.6

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

627

2281

1.84

40.98

1.5

1.3

—

Hepatomegaly and splenomegaly, not elsewhere classified

10.45

40.97

1.9

1.5

—

Diverticular disease of intestine

919

3587

1.65

40.89

1.6

1.4

—

Pain in limb

1279

5667

1.52

40.78

1.6

1.5

—

Abnormal findings on examination of urine, without diagnosis

116

298

4.10

40.56

2.4

1.4

—

Other disorders of lacrimal gland

506

2677

1.92

40.45

1.6

1.4

—

Diabetes medication

1555

6335

1.47

40.39

1.7

1.4

—

Gastroduodenal ulcer

336

1527

2.23

40.36

1.7

1.4

—

Cardiac arrest

115

242

4.18

40.25

2.1

1.2

—

Neurological diseases

1457

4937

1.49

40.17

1.4

1.5

—

Viral warts

215

806

2.75

40.16

2.5

1.4

—

Other diseases of intestine

224

856

2.67

40.02

1.6

1.5

—

Persons encountering health services in other circumstances

629

3553

1.78

39.89

1.6

1.4

—

Nonischemic cardiomyopathy

175

588

3.06

39.85

1.8

1.4

—

Volume depletion

158

501

3.24

39.72

2.2

1.4

—

Diseases of spleen

101

6.90

39.54

1.6

1.4

—

Viral and other specified intestinal infections

545

2867

1.86

39.50

2.0

1.4

—

Viral hepatitis

177

607

3.03

39.19

1.3

1.5

—

Pleural effusion

223

859

2.65

39.19

1.5

1.4

—

Convulsions, not elsewhere classified

344

1581

2.18

39.15

1.6

1.4

—

Hypertensive Heart Disease

284

936

2.41

39.11

2.2

1.2

—

Chronic hepatitis NAS

8.15

38.96

1.3

1.4

—

Other viral hepatitis

164

541

3.16

38.95

1.3

1.5

—

Iron deficiency anaemia secondary to blood loss (chronic)

240

964

2.54

38.68

1.9

1.4

—

Any operation in hilmo

9.06

38.49

1.4

1.1

—

Other obstetric conditions, not elsewhere classified

605

2134

1.83

38.46

1.3

—

L01XX Other antineoplastic agents

114

300

3.95

38.38

1.3

—

Herpesviral [herpes simplex] infections

220

853

2.65

38.34

1.7

1.4

—

Biological medication for rheuma

347

1645

2.16

38.13

1.3

1.5

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

595

2091

1.84

38.07

1.3

—

Other disorders of urethra and urinary system

993

4580

1.58

37.78

1.7

1.4

—

Disorders of sclera, cornea, iris and ciliary body

817

5058

1.63

37.53

1.6

1.4

—

Amputation of ankle bones

103

6.53

37.44

2.5

1.4

—

Abnormal findings on diagnostic imaging of other body structures

225

893

2.58

37.30

1.5

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1343

5851

1.48

37.27

1.5

—

Hypothyroidism, drug reimbursement

206

529

2.79

37.09

1.6

1.2

—

Other diseases of hard tissues of teeth

765

2338

1.71

37.00

1.5

1.3

—

Diseases of the musculoskeletal system and connective tissue

980

3092

1.60

36.99

1.5

—

Myocardial infarction

587

2307

1.81

36.92

1.6

1.4

—

Systemic lupus erythematosus, unspecified

174

5.00

36.73

1.3

1.4

—

Other specified/unspecified arthritis

423

2179

1.97

36.73

1.5

1.4

—

Heart failure and hypertrophic cardiomyopathy

7.17

36.69

1.6

1.4

—

Viral and other specified intestinal infections

436

2217

1.95

36.62

2.1

1.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

476

1994

1.91

36.45

2.0

1.3

—

Diaphragmatic hernia

461

2452

1.90

36.26

1.4

—

Gastro-oesophageal reflux disease

932

5148

1.58

36.25

1.6

1.5

—

Sequelae of external causes of morbidity and mortality

383

1923

2.02

35.85

1.9

1.4

—

Cellulitis

372

1850

2.05

35.83

2.0

1.4

—

Visual disturbances and blindness

741

4533

1.65

35.68

1.5

1.4

—

Other diseases of urinary system

1498

5873

1.44

35.64

1.6

1.4

—

Other problems related to primary support group, including family circumstances

270

1158

2.34

35.51

2.6

1.4

—

Acute pancreatitis

290

1317

2.24

35.36

1.6

1.4

—

Osteonecrosis

125

371

3.50

35.24

1.8

1.4

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

287

1303

2.26

35.23

1.3

1.5

—

Unspecified haematuria

567

2663

1.78

35.21

1.8

1.4

—

Cholelithiasis, broad definition with cholecystitis

1144

5142

1.51

35.13

1.4

—

Sarcoidosis

228

938

2.49

35.09

1.5

1.4

—

Ulcerative colitis (strict) with PSC

9.18

35.08

1.4

1.6

—

Other CVD

251

1076

2.37

35.02

1.6

1.4

—

Seborrhoeic keratosis

293

1343

2.22

34.89

1.7

1.3

—

Sequelae with surgical and medical care as external cause

301

1396

2.20

34.87

1.9

1.4

—

Secondary thrombocytopenia

8.48

34.66

1.6

1.5

—

Chronic myeloid leukaemia, including Hilmo

10.23

34.60

1.1

1.2

—

Major coronary heart disease event excluding revascularizations

706

2814

1.69

34.57

1.6

1.4

—

Other and unspecified diseases of blood and blood-forming organs

133

5.50

34.51

1.3

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

694

3342

1.68

34.51

1.7

1.4

—

Undetermined asthma, excluding more controls

190

720

2.69

34.49

1.5

1.3

—

Disorders of lacrimal system

579

3343

1.75

34.42

1.5

1.4

—

Crohn's disease NAS

153

526

3.02

33.80

1.4

1.5

—

Other ulcerative colitis

137

443

3.22

33.68

1.4

1.5

—

Soft tissue disorders

1630

6002

1.41

33.20

1.5

—

Any mental disorder

1632

5839

1.41

33.19

1.5

—

Phlebitis and thrombophlebitis (not including DVT)

329

1609

2.08

33.17

1.8

1.4

—

Benign neoplasm: Colon

653

3757

1.68

33.16

1.6

1.4

—

Undetermined asthma

190

735

2.63

33.12

1.5

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

769

4178

1.61

33.08

1.6

1.4

—

Other anxiety disorders

788

4307

1.60

32.92

1.4

—

Cystitis

1224

4974

1.47

32.83

1.5

1.4

—

Disorders of vitreous body and globe

627

3602

1.69

32.82

1.9

1.4

—

Maternal care for other known or suspected fetal problems

437

1456

1.93

32.77

1.4

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

207

841

2.52

32.73

1.5

1.3

—

Abnormalities of heart beat

492

2702

1.80

32.68

1.4

—

Coxarthrosis [arthrosis of hip](FG)

653

2742

1.69

32.65

1.3

1.5

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

9.76

32.59

1.5

1.3

—

Other embolism and thrombosis

204

825

2.53

32.56

1.6

1.4

—

Arthropathies

1494

5350

1.42

32.46

1.4

1.5

—

Pre-eclampsia or poor fetal growth

493

2767

1.80

32.39

1.5

1.3

—

Infectious mononucleosis

210

866

2.50

32.39

1.3

1.4

—

Amputation of foot

126

5.47

32.32

2.8

1.4

—

Other nutritional deficiencies

1010

6380

1.50

32.18

1.5

—

COPD-related respiratory insufficiency

172

644

2.73

32.13

1.8

1.4

—

Crohn disease (strict definition, require KELA, min 2 HDR)

151

532

2.95

31.95

1.3

1.5

—

Myeloproliferative diseases

140

472

3.05

31.88

1.3

1.4

—

Benign neoplasms

1548

6108

1.41

31.84

1.6

1.4

—

Peripheral arterial reconstruction

212

881

2.45

31.80

2.1

1.3

—

Crohn disease (strict definition, require KELA)

152

542

2.91

31.46

1.3

1.5

—

Other general symptoms and signs

102

283

3.69

31.30

1.5

—

Diabetic neuropathy

207

857

2.47

31.22

2.3

1.6

—

Marginal zone B-cell lymphoma

11.40

31.20

1.3

—

Thrombotic microangiopathy

11.33

31.14

1.4

—

Disorders of vitreous body

604

3509

1.68

31.02

1.9

1.4

—

Hypotension

210

879

2.43

31.00

1.6

1.3

—

Caries of enamel

1355

6933

1.42

30.92

1.7

1.4

—

COPD (mode)

326

1258

2.06

30.92

1.5

1.4

—

Dental operations

793

2547

1.61

30.91

1.5

1.3

—

Secondary right heart disease

208

4.21

30.85

1.6

1.3

—

Other diseases of blood and blood-forming organs

126

408

3.19

30.83

1.3

1.4

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

106

5.83

30.80

2.0

1.3

—

Candidiasis

234

1033

2.32

30.76

1.8

1.4

—

Melanocytic naevi

467

2631

1.80

30.72

1.9

1.4

—

Unspecified acute lower respiratory infection

260

1199

2.21

30.70

1.9

1.5

—

Acute pancreatitis (for exclusion)

290

1396

2.11

30.57

1.6

1.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

165

623

2.72

30.46

1.5

1.4

—

Procreative management

580

2879

1.70

30.45

1.5

1.6

—

Invasive ventilation

140

486

2.97

30.36

2.1

1.5

—

Other acute viral hepatitis

6.20

30.29

1.1

1.5

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

156

576

2.80

30.23

1.3

1.5

—

Exposure to unspecified factor

1486

7738

1.39

30.10

1.5

—

Crohn's disease of large intestine

124

406

3.18

29.93

1.4

1.5

—

Disorders of tooth development and eruption

284

1091

2.14

29.87

1.8

1.2

—

Other maternal disorders predominantly related to pregnancy

791

3162

1.58

29.82

1.4

—

Hypokalaemia

171

663

2.63

29.81

1.7

1.3

—

Gastric ulcer

223

976

2.32

29.75

1.7

1.4

—

Isolated proteinuria with specified morphological lesion

7.13

29.64

3.3

1.2

—

Coxarthrosis

620

2468

1.67

29.56

1.3

1.4

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

8.35

29.53

1.1

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

453

2560

1.79

29.46

1.5

1.4

—

Urticaria and erythema

575

3470

1.68

29.46

1.6

1.5

—

Disorders of thyroid, IBD co-morbidities

273

890

2.18

29.40

1.5

1.3

—

Acquired absence of organs, not elsewhere classified

8.34

29.37

2.5

1.1

—

Eosinophilic disease (BM)

7.04

29.33

1.3

1.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

512

2968

1.73

29.23

2.1

1.4

—

Chronic pancreatitis

195

813

2.45

29.22

1.7

1.5

—

Herpesviral [herpes simplex] infections

399

2178

1.86

29.19

1.5

1.4

—

Candidiasis

440

2478

1.80

29.01

1.6

1.4

—

Visual disturbances

674

4247

1.60

28.95

1.5

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

166

646

2.64

28.90

2.0

1.5

—

Tumor necrosis factor alpha inhibitors

296

1470

2.06

28.86

1.3

1.5

—

Hypocalcemia

140

4.95

28.73

2.2

1.5

—

Idiopathic gout

143

517

2.84

28.69

2.2

1.4

—

Disorders of oesophagus in diseases classified elsewhere

5.98

28.53

1.7

1.3

—

Disorders of skin appendages

754

4892

1.56

28.38

1.6

1.4

—

Other abnormalities of plasma proteins

6.65

28.33

1.6

1.4

—

Cholelithiasis

1062

5039

1.46

28.31

1.4

—

Episodal and paroxysmal disorders

1680

6313

1.36

28.21

1.4

1.5

—

Need for other prophylactic measures

124

421

3.05

28.09

1.8

1.5

—

Amiodarone users

157

603

2.67

28.03

1.5

1.4

—

Hypothyroidism, strict autoimmune

953

4231

1.49

27.83

1.5

1.3

—

Other and unspecified drugs and medicaments

155

596

2.67

27.67

1.5

1.4

—

Dysphagia

305

1552

1.99

27.55

1.5

1.4

—

Other coagulation defects

139

507

2.82

27.52

1.5

1.4

—

Other renal tubulo-interstitial diseases

114

5.25

27.34

2.2

1.4

—

Hypoplasia of dental enamel, prenatal

15.02

27.31

6.1

2.1

—

Acute pharyngitis

296

1486

2.01

27.30

1.6

1.5

—

Other and unspecified local infections of skin and subcutaneous tissue

174

714

2.50

27.11

1.9

1.5

—

Other pulmonary heart/vessel disease

247

3.69

27.10

1.5

1.4

—

Other and unspecified coagulation defects

107

342

3.25

26.90

1.4

—

Other functional intestinal disorders

603

3492

1.62

26.66

1.6

1.5

—

Other and unspecified acquired haemolytic anaemias

8.17

26.40

1.7

1.3

—

Chronic myeloproliferative disease

7.31

26.30

1.5

—

Myocardial infarction, strict

515

2181

1.70

26.29

1.6

1.4

—

Missing teeth due to accident, extraction or parodontitis

727

4479

1.54

26.27

1.7

1.4

—

Osteopathy in diseases classified elsewhere

9.16

26.24

2.0

1.6

—

Acute lymphocytic leukaemia, helper endpoint

6.52

26.20

1.5

1.8

—

Acute lymphocytic leukaemia

6.52

26.20

1.5

1.8

—

Acute lymphocytic leukaemia, including Hilmo

6.52

26.20

1.5

1.8

—

Other diseases of arteries and capillaries

141

531

2.72

26.19

2.0

1.4

—

Vocal cord dysfunction

191

738

2.36

25.97

1.5

1.3

—

Shock, not elsewhere classified

10.77

25.92

2.4

1.3

—

Osteonecrosis due to drugs

6.52

25.92

1.7

1.4

—

Coxarthrosis, primary, with hip surgery

508

2867

1.67

25.80

1.2

1.4

—

Obesity related asthma

480

2863

1.70

25.80

1.5

1.4

—

Intestinal stricture

381

2133

1.81

25.63

1.4

—

Cystic disease of liver

9.57

25.49

1.7

1.3

—

Other congenital malformations of the digestive system

124

444

2.90

25.36

2.6

1.8

—

Pruritus

181

779

2.37

25.34

1.7

1.4

—

Other local infections of skin and subcutaneous tissue

178

761

2.39

25.34

1.9

1.5

—

Microscopic polyangiitis

11.39

25.27

2.3

1.7

—

Iridocyclitis

335

1816

1.87

25.14

1.6

1.4

—

Mixed connective tissue disease

114

393

2.99

25.11

1.4

1.3

—

Paralytic ileus and intestinal obstruction

312

1655

1.91

24.91

1.4

—

Use of hypnotics and sedatives

1487

6340

1.35

24.73

1.5

—

Asthma (diagnoses ohter than nonallergic)

1247

7553

1.38

24.57

1.5

—

Obesity

922

6192

1.45

24.56

1.5

1.4

—

Nonhereditary hypogammaglobulinemia

6.84

24.49

1.3

1.4

—

Collagenous colitis

148

592

2.56

24.38

1.4

—

Other diseases of anus and rectum

375

2116

1.79

24.38

1.5

1.4

—

Acute nephritic syndrome

143

4.54

24.33

2.6

1.4

—

Obesity and other hyperalimentation

924

6214

1.44

24.25

1.5

1.4

—

Nonorganic sleeping disorders, excluding more controls

317

1709

1.88

24.25

1.5

1.4

—

Poor fetal growth

244

1206

2.07

24.24

1.4

1.3

—

Fentanyl

129

482

2.72

24.18

1.5

1.4

—

Low back pain

1104

5678

1.40

23.93

1.4

1.5

—

Diabetes mellitus in pregnancy

510

1979

1.67

23.93

1.5

1.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

202

932

2.21

23.91

2.0

1.4

—

Subjective visual disturbances

356

2000

1.80

23.79

1.4

—

Non-allergic asthma (mode), excluding more controls

230

1108

2.08

23.59

1.6

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

102

342

3.05

23.52

2.1

1.2

—

Constipation

1170

5868

1.39

23.52

1.5

—

Chorioretinal inflammation

177

4.03

23.49

1.3

1.4

—

Elevated blood glucose level

140

556

2.58

23.45

1.9

1.5

—

Other specific joint derangements/joint disorders

1115

5175

1.40

23.41

1.5

—

Hypercalcemia

239

3.52

23.21

2.0

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

117

424

2.79

23.18

1.5

1.3

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.27

23.09

1.7

1.5

—

Other specified/unspecified systemic involvement of connective tissue

100

336

3.06

23.07

1.4

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

1537

5992

1.34

22.97

1.4

—

405

2177

1.72

22.86

1.5

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

467

1905

1.67

22.73

1.6

1.4

—

Other specified disorders of kidney and ureter

186

3.87

22.66

2.4

1.3

—

Chronic ulcer of skin, not elsewhere classified

105

366

2.94

22.64

2.6

1.3

—

Melanocytic naevi of trunk

200

944

2.16

22.47

1.9

1.4

—

Sleep apnoea

1225

5832

1.37

22.26

1.4

1.5

—

Lichen simplex chronicus and prurigo

107

381

2.89

22.25

1.7

1.4

—

Dermatitis due to substances taken internally

106

376

2.91

22.24

1.7

1.4

—

Other congenital malformations of the digestive system

129

504

2.64

22.21

2.5

1.8

—

Diseases of pulp and periapical tissues and dental caries

870

3064

1.46

22.20

1.5

1.4

—

Crohn's disease of small intestine

137

554

2.54

22.19

1.3

1.5

—

Disorder of lipoprotein metabolism, unspecified

162

704

2.34

22.16

1.6

1.3

—

Malignant neoplasm of digestive organs

369

1667

1.76

22.15

1.3

1.5

—

Viral warts

349

1999

1.77

21.93

2.1

1.4

—

Other arrhythmias

799

4150

1.46

21.79

1.5

1.4

—

Non-allergic asthma (mode)

230

1143

2.02

21.71

1.6

1.4

—

Liver disorders in diseases classified elsewhere

23.68

21.67

1.3

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.70

21.65

5.1

2.0

—

Recurrent or chronic depression

633

2922

1.54

21.64

1.4

1.5

—

Malignant neoplasm of skin

482

2031

1.64

21.60

1.5

1.4

—

Generalized skin eruption due to drugs and medicaments

261

3.30

21.55

1.8

1.5

—

Ulcerative ileocolitis

292

3.16

21.53

1.3

1.5

—

Hernia

1251

6225

1.35

21.52

1.7

1.5

—

Type 2 diabetes, definitions combined

1192

5144

1.37

21.36

1.5

1.3

—

Actinic keratosis

360

1933

1.74

21.22

1.5

1.3

—

Adalimumab

184

863

2.18

21.11

1.3

1.5

—

Other arterial embolism and thrombosis

128

4.38

21.09

2.7

1.4

—

Neovascular glaucoma

229

3.43

21.08

2.1

1.4

—

Malignant immunoproliferative diseases

6.70

21.07

2.0

1.6

—

Recurrent aphthous stomatitis , including avohilmo

229

1165

2.00

21.00

1.6

1.4

—

Acute posthaemorrhagic anaemia

150

4.06

20.96

1.8

1.3

—

Cholecystitis

169

766

2.24

20.93

1.5

1.4

—

Skin changes due to chronic exposure to nonionizing radiation

368

1994

1.72

20.70

1.5

1.3

—

Renal agenesis and other reduction defects of kidney

7.57

20.69

2.0

1.5

—

Pregnancy examination and test

270

879

1.94

20.65

1.3

1.4

—

Other or unspecified ileus, impaction or obstruction

216

1081

2.02

20.60

1.4

—

Anterior Iridocyclitis

290

1603

1.83

20.57

1.7

1.4

—

Amyloidosis, other/unspecified

5.21

20.45

1.6

1.4

—

Diseases of middle ear and mastoid

895

5224

1.41

20.41

1.6

1.4

—

Other antidepressants

1476

5759

1.32

20.34

1.4

1.5

—

Special screening examination for infectious and parasitic diseases

378

1640

1.71

20.34

1.3

1.4

—

Other/unspecified dorsalgia

508

3234

1.57

20.28

1.5

—

Other neurological diseases

868

4841

1.42

20.24

1.5

1.4

—

Cardiodefibrillation

397

2399

1.67

20.22

1.5

1.4

—

Benign neoplasm: Colon, unspecified

285

1574

1.83

20.22

1.5

1.4

—

Dental caries, including avohilmo

966

3526

1.41

20.19

1.6

1.4

—

Functional dyspepsia

338

1963

1.74

20.17

1.5

1.4

—

Other obstructive and reflux uropathy

266

3.18

20.17

2.2

1.3

—

Type 2 diabetes, strict (exclude DM1)

1196

5213

1.35

20.15

1.5

1.4

—

Use of pramipexole

267

1448

1.87

20.11

1.9

1.4

—

Acute and subacute iridocyclitis

275

1509

1.85

20.00

1.7

1.4

—

Glaucoma secondary to other eye disorders

237

3.31

19.98

2.1

1.4

—

Injuries to the ankle and foot

1059

6943

1.36

19.94

1.6

1.5

—

Obesity due to excess calories

679

4657

1.47

19.85

1.5

—

Amyloidosis

105

4.68

19.84

1.6

1.4

—

Renal agenesis and other reduction defects of kidney

7.82

19.81

2.0

1.5

—

Benign neoplasm of other and ill-defined parts of digestive system

220

1127

1.98

19.74

1.5

1.4

—

Migraine

768

4351

1.44

19.72

1.4

1.5

—

Covid-19 suspected case

345

2031

1.72

19.69

1.6

1.4

—

Aspergillosis

6.89

19.69

2.1

1.4

—

Decubitus ulcer and pressure area

301

2.99

19.69

2.4

1.3

—

Calcific aortic valvular stenosis

288

1556

1.81

19.68

1.6

1.4

—

Calcific aortic valvular stenosis, operated

288

1556

1.81

19.68

1.6

1.4

—

Operations 2 for CAVS

286

1542

1.81

19.68

1.6

1.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

286

1542

1.81

19.68

1.6

1.4

—

Calcific aortic valvular stenosis, including rheumatic fever

287

1548

1.81

19.66

1.6

1.4

—

Acute generalized exanthematous pustulosis

292

3.04

19.61

1.8

1.5

—

Coxarthrosis, primary

625

3559

1.50

19.60

1.2

1.4

—

AV-block

191

809

2.09

19.59

1.7

1.4

—

Other symptoms and signs involving the digestive system and abdomen

207

1041

2.01

19.55

1.6

1.4

—

Eosinophilia

107

4.68

19.52

1.5

—

Crohn disease (strict definition, all UC cases excluded)

107

410

2.70

19.47

1.2

1.5

—

Arterial embolism and thrombosis

271

3.09

19.45

2.3

1.3

—

Spondylopathies in diseases classified elsewhere

6.87

19.45

1.5

1.6

—

Background retinopathy and retinal vascular changes

111

4.54

19.45

2.0

1.5

—

Urticaria

453

2869

1.60

19.33

1.6

1.4

—

Disorders of eyelid, lacrimal system and orbit

1096

6183

1.35

19.24

1.5

1.4

—

Habitual aborter

161

3.85

19.17

1.6

1.4

—

Postpartum care and examination

240

787

1.96

19.15

1.4

—

Other specified/unspecified necrotizing vasculopathies

5.80

19.11

2.4

1.5

—

Explicit fungal Sepsis

8.86

19.11

1.6

1.4

—

Drug-induced adrenocortical insufficiency

105

4.63

19.00

1.5

—

Caries of dentine, including avohilmo

1061

3975

1.37

18.89

1.5

1.4

—

Rare circulating lymphoid malignancy

20.08

18.87

1.3

1.5

—

Asthma, hospital admissions , main diagnosis only

1143

7588

1.34

18.81

1.5

—

Other and unspecified tonsillitis

576

3240

1.51

18.68

1.7

1.4

—

Cerebrovascular diseases

839

4207

1.41

18.67

1.6

1.4

—

Stomatitis and related lesions

295

1690

1.77

18.62

1.6

1.4

—

Angina pectoris

586

2600

1.51

18.60

1.6

1.4

—

Unknown and unspecified causes of morbidity

338

2.80

18.59

1.7

1.4

—

Cholecystectomy

842

5220

1.40

18.54

1.4

—

Type 2 diabetes, definitions combined, including avohilmo

1193

5226

1.34

18.43

1.5

1.4

—

Unspecified privation

169

809

2.13

18.40

1.7

1.4

—

Hypoglycaemia, other or unspecified

125

530

2.42

18.33

2.0

1.6

—

Dorsalgia

1436

5934

1.30

18.25

1.4

1.5

—

Psychiatric diseases

1400

5384

1.31

18.18

1.5

—

Other abnormal products of conception

491

2096

1.57

18.15

1.4

—

Alcohol use disorder, Swedish definition

744

4827

1.42

18.15

1.5

—

Other diseases of pancreas

115

471

2.49

18.13

1.8

1.4

—

Depression or dysthymia

957

3848

1.38

18.07

1.5

—

Myocardial infarction, without ST-elevation

410

2342

1.61

17.97

1.6

1.4

—

Dermatopolymyositis (FG)

5.44

17.94

1.4

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

117

485

2.45

17.92

1.9

1.5

—

Acute suppurative otitis media

484

2954

1.55

17.83

1.8

1.4

—

Acute lymphadenitis

113

464

2.50

17.81

1.5

—

Wegener granulomatosis

4.74

17.81

1.9

1.4

—

Other congenital malformations of urinary system

6.63

17.73

4.6

1.5

—

Fibromyalgia

140

632

2.26

17.68

1.2

1.4

—

Irregular menses

666

3654

1.45

17.64

1.4

—

Hernia of abdominal wall

569

3863

1.48

17.59

1.8

1.4

—

Dermatophytosis

181

904

2.04

17.56

1.8

1.4

—

Other complications of surgical and medical care, not elsewhere classified

147

679

2.21

17.55

1.6

1.3

—

Early onset COPD

287

1663

1.75

17.41

1.5

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.98

17.38

2.2

1.5

—

Ulcerative rectosigmoiditis

139

634

2.24

17.18

1.4

1.5

—

Myalgia

326

1963

1.68

17.14

1.4

—

Outcome of delivery

262

895

1.84

17.12

1.3

1.4

—

Erythema multiforme

132

3.95

17.01

1.3

1.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

600

3590

1.46

16.99

1.5

1.3

—

Misadventures to patients during surgical and medical care

188

963

1.98

16.97

1.9

1.3

—

Fluid overload

18.36

16.87

2.6

1.1

—

Cardiomyopathy, Hypertrophic obstructive

4.57

16.81

1.8

1.4

—

Disease of hard tissues of teeth, NOS

639

2292

1.47

16.79

1.4

1.3

—

789

5172

1.39

16.66

1.4

1.5

—

External causes of morbidity and mortality

983

3642

1.36

16.63

1.4

—

Childhood asthma (age<16), excluding more controls

252

1111

1.81

16.62

1.5

1.3

—

Chronic myeloid leukaemia

21.41

16.60

1.2

1.1

—

Malignant neoplasm of urinary organs

108

448

2.45

16.55

1.9

1.4

—

Medullary cystic kidney disease, nephronophthisis

34.84

16.54

2.6

1.3

—

Hypertrophic cardiomyopathy

271

2.94

16.54

1.7

1.5

—

Keratitis

471

3122

1.52

16.44

1.7

1.4

—

Sleep apnoea, including avohilmo

1283

6149

1.30

16.42

1.4

1.5

—

Dorsopathies

1514

6055

1.28

16.40

1.4

1.5

—

Nonorganic sleeping disorders

317

1922

1.67

16.31

1.5

1.4

—

Hypersensitivity angiitis

14.88

16.29

2.4

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

404

1753

1.59

16.26

1.5

1.4

—

Encephalopathy

5.74

16.18

1.2

1.5

—

Abnormality of white blood cells, not elsewhere classified

6.17

16.18

1.8

1.4

—

Ulcerative enterocolitis

221

3.15

16.17

1.3

1.6

—

Congenital malformation of biliary tract

7.47

16.16

4.0

1.9

—

823

5319

1.37

16.13

1.5

—

Retinal haemorrhage

110

4.15

16.10

1.8

1.3

—

Hypersplenism

14.52

16.09

1.7

1.3

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

225

1226

1.83

16.07

1.2

1.5

—

Pregnancy hypertension

549

3367

1.47

16.07

1.5

1.3

—

Polyarteritis nodosa and related conditions

4.68

15.91

1.4

—

Conjunctivitis (acute, non atopic)

413

2672

1.56

15.91

1.8

1.5

—

Acquired absence of limb

6.40

15.82

3.1

1.2

—

Cytomegaloviral hepatitis

17.26

15.81

1.3

—

Nerve, nerve root and plexus disorders

1380

6634

1.28

15.80

1.6

1.4

—

Chronic lower respiratory diseases

1715

7335

1.25

15.75

1.5

—

Other diseases of stomach and duodenum

334

2.66

15.75

1.8

1.4

—

Prurigo nodularis

126

3.88

15.65

1.6

1.4

—

Sleep disorders (combined)

1568

6546

1.26

15.64

1.4

1.5

—

Childhood asthma (age<16)

252

1133

1.78

15.62

1.5

1.3

—

Fibrosis of liver

6.45

15.60

2.0

1.3

—

Suppurative and unspecified otitis media

599

3720

1.44

15.53

1.6

1.4

—

Primary coxarthrosis, bilateral

284

1693

1.69

15.53

1.3

1.4

—

Irritable bowel syndrome

360

2278

1.60

15.52

1.5

1.4

—

Retinal detachments and breaks

379

2426

1.57

15.52

1.7

1.3

—

Disorders of conjunctiva

1156

7178

1.30

15.52

1.5

—

DVT of lower extremities

215

1186

1.83

15.46

1.6

1.4

—

Erosion of teeth , including avohilmo

387

2496

1.57

15.43

2.1

1.4

—

Corns and callosities

403

2.48

15.41

2.1

1.4

—

Injury, poisoning and certain other consequences of external causes

806

2932

1.39

15.39

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

171

881

1.98

15.33

2.1

1.6

—

Haemorrhage in early pregnancy

353

2170

1.60

15.30

1.4

1.3

—

Haemophagocytic lymphohistiocytosis

37.44

15.25

1.4

—

Conduction disorders

313

1546

1.65

15.22

1.6

1.3

—

Encephalitis

208

3.15

15.22

1.2

1.5

—

Adult respiratory distress syndrome

5.06

15.18

2.2

1.5

—

Dermatopolymyositis

4.69

15.17

1.4

—

Post-traumatic stress disorder

159

802

2.02

15.15

1.4

1.3

—

Drug-induced hypoglycaemia without coma

4.29

15.13

1.7

1.3

—

Rosacea

164

836

1.99

15.11

1.6

1.4

—

Adrenocortical insufficiency

214

3.09

15.08

1.6

1.5

—

Malignant neoplasm of kidney, except renal pelvis

413

2.44

15.04

1.9

1.4

—

Squamous cell neoplasms and carcinomas of the skin

278

2.77

15.04

1.4

1.2

—

Infection due to other mycobacteria

5.39

15.00

1.4

1.3

—

Fall on same level

1645

7228

1.25

14.95

1.5

—

Other encephalitis

195

3.20

14.90

1.2

1.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

691

4867

1.39

14.86

1.5

—

In situ neoplasms

416

2746

1.53

14.84

1.5

1.3

—

Viral infections of the central nervous system

122

562

2.22

14.78

1.3

1.4

—

Other disorders of adrenal gland

317

2.66

14.75

1.5

—

Drug-induced systemic lupus erythematosus

7.16

14.75

1.3

1.5

—

Spondyloarthritis

240

1388

1.75

14.73

1.4

—

Umbilical hernia

360

2309

1.57

14.70

1.9

1.4

—

Other dorsopathies, not elsewhere classified

1437

5969

1.27

14.64

1.4

1.5

—

Inflammatory diseases of the central nervous system

130

617

2.15

14.60

1.4

1.5

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

13.89

14.60

1.3

1.9

—

Polymyalgia rheumatica

134

642

2.11

14.59

1.2

1.3

—

Other leukaemias of specified cell type

25.14

14.56

1.6

1.5

—

Lower back pain or/and sciatica

1413

7352

1.26

14.49

1.4

1.5

—

Carcinoma in situ of skin

409

2.41

14.43

1.8

1.2

—

Drug-induced polyneuropathy

5.33

14.36

1.5

1.7

—

Falls/tendency to fall

1585

6380

1.25

14.36

1.5

—

Disorders of the thyroid gland

1256

6439

1.28

14.25

1.5

1.4

—

Special screening examination for other diseases and disorders

146

729

2.03

14.22

2.0

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

430

2887

1.50

14.20

1.5

—

Discitis, unspecified

4.61

14.18

1.6

1.5

—

Other overlap syndromes

4.22

14.17

1.4

1.5

—

Lupus nephritis

17.01

14.10

1.4

1.5

—

Mycoses

1152

7862

1.28

14.01

1.5

—

Diseases of the ear and mastoid process

1655

6730

1.24

14.00

1.5

1.4

—

Phobic anxiety disorders

232

1350

1.74

13.96

1.6

1.4

—

Other joint disorders

1279

5313

1.28

13.95

1.4

1.5

—

Supervision of high-risk pregnancy

296

1081

1.67

13.94

1.3

1.4

—

Adverse effects, not elsewhere classified

297

1849

1.63

13.85

1.5

1.4

—

L04AC Interleukin inhibitors

106

475

2.29

13.82

1.2

1.5

—

Rheumatoid arthritis

361

2099

1.55

13.81

1.3

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

718

5303

1.36

13.80

1.5

—

Myeloproliferative diseases (CML excluded)

431

2.34

13.75

1.3

—

Systemic sclerosis (FG)

105

3.94

13.72

1.4

1.5

—

Pregnancy with abortive outcome

813

3147

1.36

13.72

1.3

—

Accidents

1189

4656

1.28

13.66

1.4

1.5

—

Late syphilis

4.41

13.65

2.5

1.4

—

Pre-eclampsia or eclampsia

284

1755

1.64

13.63

1.6

1.3

—

Recurrent and persistent haematuria

5.38

13.63

1.9

1.3

—

Gestational diabetes (for exclusion)

545

2660

1.44

13.61

1.4

—

Hypertension, portal

15.66

13.60

1.4

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

10.51

13.55

1.6

1.2

—

Use of antiglaucoma preparations and miotics

373

2.42

13.44

1.7

1.2

—

Viral infections of the central nervous system

112

519

2.20

13.42

1.3

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

427

2898

1.49

13.39

1.5

—

Spontaneous abortion

579

2774

1.42

13.35

1.4

1.3

—

Emphysema

407

2.35

13.22

1.4

—

Artificial opening status

287

2.63

13.21

1.8

1.1

—

Sicca syndrome [Sjögren]

108

496

2.21

13.20

1.3

—

Benzodiazepine use

1333

7352

1.25

13.19

1.4

1.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1260

6838

1.26

13.16

1.4

1.5

—

Fracture of foot, except ankle

349

2284

1.54

13.10

1.7

1.4

—

Reactive arthropathies

124

604

2.09

13.04

1.3

1.4

—

Melanocytic naevi, other sites/unspecified

125

612

2.08

13.00

2.2

1.4

—

Weight loss

139

708

2.00

12.93

1.6

1.4

—

Other follicular disorders

118

567

2.12

12.91

2.0

1.5

—

Speech and linguistic disorders, excluding more controls

162

819

1.90

12.77

2.2

1.5

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

198

3.03

12.76

2.9

1.6

—

Crohn's disease (strict) with PSC

19.80

12.74

1.2

1.4

—

Rash and other nonspecific skin eruption

134

678

2.01

12.71

1.6

1.4

—

Aortic valve malfunction, age under 60 years

150

790

1.93

12.70

2.1

1.6

—

Acute bronchiolitis

149

703

1.96

12.69

2.2

1.7

—

Pulmonary oedema

4.63

12.69

2.3

1.4

—

Seborrhoeic dermatitis

132

665

2.02

12.67

1.6

1.4

—

Haemolytic-uraemic syndrome

13.55

12.67

2.6

1.7

—

Excessive, frequent and irregular menstruation

536

2066

1.43

12.63

1.4

1.3

—

Obesity, other/unspecified

461

3214

1.45

12.61

1.5

1.4

—

Membranous nephropathy

11.63

12.53

2.7

1.5

—

Other disorders starting during childhood or adolecense, excluding more controls

114

524

2.14

12.50

2.3

1.6

—

Unspecified contracted kidney

9.64

12.43

2.3

1.2

—

Other external causes of accidental injury

1176

4656

1.27

12.42

1.4

1.5

—

Asthma, including avohilmo

1627

7508

1.22

12.32

1.4

1.5

—

Chronic iridocyclitis

334

2.45

12.30

1.4

1.5

—

Vascular disorders of the intestines

291

2.55

12.29

1.6

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

347

1547

1.54

12.25

1.3

1.4

—

Other and unspecified rosacea

116

565

2.09

12.24

1.6

1.4

—

Systemic sclerosis

114

3.62

12.23

1.4

1.5

—

Open wound of ankle and foot

160

871

1.87

12.22

1.9

1.4

—

Small fibre neuropathy

175

3.07

12.21

1.8

1.4

—

Speech therapy

303

1954

1.56

12.17

1.7

1.4

—

Benign neoplasm: Transverse colon

130

661

2.00

12.17

1.7

1.4

—

Special screening examination for neoplasms

282

2.56

12.08

1.4

1.3

—

Portal vein thrombosis

3.98

12.08

1.9

1.4

—

Osteoporosis with pathological fracture (FG)

276

2.57

12.07

1.3

—

Other mycoses, not elsewhere classified/unspecified

11.81

12.07

1.9

1.3

—

Sulfasalazine

317

2070

1.54

12.02

1.3

1.4

—

Other specified/unspecified bacterial intestinal infections

419

2.26

11.99

1.5

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

344

2.39

11.92

1.7

1.2

—

Abnormal weight loss

125

633

2.01

11.87

1.4

—

Hyperkinetic disorders, excluding more controls

221

1272

1.69

11.86

1.7

1.5

—

Drug-induced osteoporosis

4.80

11.81

1.4

1.3

—

Conjunctivitis

1030

6805

1.27

11.78

1.5

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

4.13

11.76

1.1

1.2

—

Other and unspecified follicular disorders

275

2.58

11.75

2.1

1.5

—

Malignant neoplasm of small intestine

3.95

11.75

1.6

1.3

—

Erectile dysfunction

104

495

2.14

11.70

1.7

1.5

—

Other diseases of lip and oral mucosa

482

3435

1.41

11.69

1.5

1.4

—

Late syphilis

3.80

11.67

2.5

1.4

—

Total colectomy

300

2.50

11.66

1.4

1.5

—

Total colectomy operation

300

2.50

11.66

1.4

1.5

—

Acidosis

123

3.46

11.65

2.5

1.3

—

Polymyositis

6.03

11.64

1.6

1.5

—

False labour

420

1799

1.47

11.60

1.3

1.4

—

Other and unspecified effects of external causes

404

2795

1.46

11.60

1.5

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

479

3377

1.41

11.59

1.6

1.4

—

Pre-eclampsia

262

1656

1.60

11.55

1.6

1.3

—

Colectomy operation

188

1091

1.74

11.54

1.3

1.4

—

Carcinoma in situ of skin of trunk

139

3.25

11.46

1.5

1.3

—

Traction detachment of retina

5.44

11.44

2.6

1.2

—

Infection of intervertebral disc (pyogenic)

4.41

11.43

2.0

1.5

—

Other headache syndromes

528

3832

1.39

11.42

1.3

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

353

2.37

11.42

2.2

1.5

—

Visual impairment including blindness (binocular or monocular)

402

2.25

11.40

1.8

1.4

—

Disturbances of skin sensation

361

2453

1.48

11.37

1.3

1.4

—

Lung diseases due to external agents

152

832

1.85

11.37

1.4

—

Delirium, not induced by alcohol and other psychoactive substances

122

620

1.99

11.36

1.6

1.3

—

Exclusions for E4_PCOS_BROAD

253

1595

1.60

11.28

1.7

1.6

—

Diseases of salivary glands

390

2694

1.46

11.28

1.5

1.4

—

Hyphaema and other vascular disorders of iris and ciliary body

111

3.55

11.25

1.9

1.4

—

Giant cell arteritis

189

2.87

11.19

1.1

1.3

—

Ventral hernia

261

1660

1.59

11.18

1.6

1.4

—

Nonalcoholic steatohepatitis

4.95

11.15

1.2

1.4

—

Other (not insulin) diabetes medications

1151

5475

1.25

11.14

1.5

1.4

—

Rheumatoid arthritis, including avohilmo

408

2848

1.44

11.13

1.3

1.4

—

Carrier of infectious disease

163

3.05

11.13

1.6

1.4

—

Basal cell carcinoma

358

1668

1.49

11.09

1.6

1.4

—

Other disorders of conjunctiva

162

912

1.80

11.08

1.8

1.4

—

Chronic sinusitis

533

3897

1.37

11.04

1.4

1.5

—

Transport accidents

651

4212

1.34

11.04

1.5

—

Malignant melanoma, including Hilmo

157

876

1.81

11.03

1.5

1.4

—

Migraine with aura

356

2430

1.48

10.98

1.3

1.4

—

Vasculitis limited to skin, not elsewhere classified

143

3.17

10.98

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

210

1276

1.66

10.86

1.5

1.3

—

Symptoms and signs involving speech and voice

364

2500

1.47

10.86

1.4

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

139

743

1.88

10.79

1.9

1.6

—

Systemic sclerosis, icd10

124

3.33

10.79

1.4

—

Other diseases of gallbladder

227

2.65

10.78

1.5

1.3

—

Abnormal findings on antenatal screening of mother

135

726

1.89

10.78

1.4

1.3

—

Disorders of continuity of bone

137

741

1.88

10.73

1.7

1.5

—

Retinal vascular disorders

119

614

1.96

10.70

1.6

1.3

—

Complications following infusion, transfusion and therapeutic injection

3.79

10.67

2.3

1.3

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

111

561

2.01

10.66

1.6

1.3

—

Infliximab

157

3.06

10.65

1.3

1.4

—

Personality disorders, excluding more controls

361

2486

1.46

10.64

1.3

1.4

—

Stroke, excluding SAH

610

3325

1.35

10.60

1.6

1.4

—

Panic disorder

231

1449

1.61

10.59

1.4

—

Other diseases of upper respiratory tract

1467

6310

1.22

10.58

1.4

1.5

—

Nonsuppurative otitis media

394

2383

1.44

10.57

1.8

1.4

—

Haemorrhoids and perianal venous thrombosis

334

2263

1.48

10.55

1.4

—

Other and unspecified vasculitis limited to skin

131

3.23

10.54

1.4

—

Ulcerative proctitis

469

2.11

10.54

1.3

1.5

—

Atopic dermatitis

818

5232

1.29

10.51

1.4

1.5

—

Hypothyroidism, other/unspecified

1139

6058

1.24

10.43

1.5

1.4

—

Seropositive rheumatoid arthritis

245

1555

1.58

10.43

1.3

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1173

6243

1.24

10.42

1.5

1.4

—

Exposure to other specified factors

1018

7506

1.25

10.41

1.5

—

Allergic asthma (mode), excluding more controls

282

1815

1.53

10.39

1.4

1.3

—

Cytomegaloviral pneumonitis

25.23

10.36

1.8

1.6

—

COPD, hospital admission 2, with asthma infections

308

1763

1.51

10.36

1.5

1.4

—

Lack of expected normal physiological development

186

2.73

10.33

3.1

1.5

—

Retinal vascular occlusion

117

608

1.95

10.32

1.6

1.3

—

Cyst of kidney

400

2.19

10.30

1.8

1.3

—

Retinal detachment with retinal break

144

801

1.82

10.29

1.8

1.3

—

Fracture of lumbar spine and pelvis

220

1370

1.62

10.27

1.6

1.4

—

Intestinal malabsorption

312

2.36

10.26

2.0

1.5

—

Other disorders of optic [2nd] nerve and visual pathways

468

2.09

10.22

1.9

1.5

—

Somatoform disorder

209

1291

1.64

10.20

1.3

1.4

—

Excessive vomiting in pregnancy

116

605

1.95

10.18

1.3

—

conjunctival haemorrhage

442

2.12

10.15

1.6

1.4

—

Other inflammation of eyelid

169

991

1.73

10.08

1.7

1.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

405

2879

1.42

10.07

1.7

1.4

—

Migraine without aura

307

2074

1.49

10.05

1.4

1.5

—

Pyogenic arthritis

404

2.16

10.05

1.6

1.5

—

Reactive arthropathies, FINNGEN

491

2.05

10.04

1.3

1.5

—

Polycystic ovarian syndrome, consortium definition

872

4065

1.28

10.00

1.4

1.3

—

Other sleep disorders

153

875

1.77

9.99

1.4

1.5

—

COPD related to multimorbidity

372

2193

1.44

9.96

1.5

1.4

—

Preterm labour and delivery

301

2028

1.50

9.95

1.4

—

Voice disturbances

293

1964

1.50

9.94

1.4

—

Syphilis

174

2.85

9.93

2.1

1.4

—

Syphilis

174

2.85

9.93

2.1

1.4

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

202

2.69

9.92

1.4

—

Congenital malformations of the circulatory system

226

1390

1.60

9.91

2.0

1.7

—

Infections with a predominantly sexual mode of transmission

592

4168

1.33

9.90

1.5

1.4

—

Otitis media, unspecified

199

1126

1.65

9.87

2.1

1.5

—

Diseases of external ear

408

2916

1.41

9.84

1.7

1.5

—

Thyroiditis, ILD-related definition

149

850

1.78

9.82

1.5

1.4

—

Malignant neoplasm of other connective and soft tissue

116

3.28

9.81

1.9

1.3

—

Viral agents as the cause of diseases classified to other chapters

159

2.93

9.79

2.2

1.6

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.76

9.76

1.3

1.6

—

Retention of urine

345

1956

1.46

9.75

1.6

1.4

—

Dermatographic urticaria

490

2.04

9.75

1.6

1.4

—

Acne

194

1191

1.65

9.74

1.8

1.4

—

Stroke, including SAH

647

3581

1.32

9.72

1.6

1.4

—

Duodenal ulcer

109

565

1.95

9.71

1.7

1.4

—

Temporal arteritis

159

2.89

9.71

1.1

1.3

—

Other symptoms and signs involving the circulatory and respiratory systems

431

2.10

9.63

1.8

1.4

—

Pneumonia derived septicemia

247

2.49

9.63

1.9

1.5

—

Diseases of tongue

327

2.27

9.60

1.8

1.2

—

Myositis

155

2.92

9.59

1.7

1.4

—

Basal cell carcinoma, including avohilmo

370

1780

1.44

9.58

1.6

1.4

—

Other abnormal findings of blood chemistry

284

2.37

9.58

1.5

1.4

—

Valvular operations

146

834

1.77

9.55

1.7

1.4

—

Substance abuse, excluding more controls

693

4576

1.30

9.55

1.4

1.5

—

Malignant melanoma

130

718

1.83

9.52

1.5

1.4

—

Other and unspecified urticaria

268

1783

1.52

9.49

1.6

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

390

2475

1.42

9.47

1.8

1.5

—

Other and unspecified vascular occlusions

447

2.06

9.46

1.7

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

232

1499

1.56

9.42

1.3

—

Acute gastritis

415

2.10

9.39

1.4

—

Human immunodeficiency virus [HIV] disease

152

2.95

9.38

1.1

1.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

248

1382

1.54

9.36

1.5

1.4

—

Dissociative [conversion] disorders

275

2.38

9.34

1.1

1.4

—

Chronic viral hepatitis

451

2.06

9.33

1.3

1.5

—

Inflammatory diseases of female pelvic organs

726

4162

1.29

9.31

1.4

1.3

—

Open wound of lower leg

196

1221

1.62

9.30

1.9

1.5

—

Injuries to the thorax

521

3905

1.34

9.29

1.6

1.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

286

1776

1.49

9.28

1.4

—

Type of accident

369

2622

1.42

9.25

1.7

1.4

—

Other disorders of eye and adnexa

189

1170

1.63

9.22

1.6

1.4

—

Cardiac murmurs and other cardiac sounds

144

820

1.76

9.21

1.7

1.6

—

Other and unspecified iridocyclitis

302

2.30

9.20

1.4

—

Allergic asthma (mode)

282

1866

1.49

9.17

1.4

—

Malignant neoplasm of head and neck

392

2.12

9.17

1.2

1.5

—

Degeneration of macula and posterior pole

405

2316

1.40

9.15

1.6

1.3

—

Unspecific neurodegenerative disorder

136

1599

0.58

9.11

1.3

—

Use of anticholinesterases

1376

0.52

9.01

1.3

1.2

—

N06DA Anticholinesterases

1376

0.52

9.01

1.3

1.2

—

Diseases of male genital organs

721

2825

1.29

9.00

1.7

1.6

—

Giant cell arteritis with polymyalgia rheumatica

166

2.77

8.99

1.1

1.3

—

Respiratory conditions due to other external agents

3.47

8.99

1.4

1.3

—

Allergic purpura

213

2.56

8.98

1.9

1.5

—

Calcinosis cutis

19.72

8.97

2.3

1.3

—

Noninflammatory disorders of female genital tract

563

2121

1.34

8.97

1.3

—

Family history of certain disabilities and chronic diseases leading to disablement

344

2.19

8.96

1.5

1.2

—

Other peripheral vascular diseases

512

1.96

8.96

1.3

—

Atopic dermatitis, strict definition with reimbursement

457

3264

1.36

8.95

1.5

—

Sickle-cell disorders

11.72

8.93

2.1

1.3

—

Bacterial, viral and other infectious agents

130

735

1.80

8.92

2.2

1.6

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.41

8.92

1.6

1.3

—

Benign neoplasm: Stomach

106

562

1.91

8.90

1.6

1.3

—

Generalized anxiety disorder

243

1607

1.53

8.90

1.3

1.4

—

Other epidermal thickening

275

2.34

8.88

1.7

1.4

—

Disorders of muscles

132

750

1.78

8.87

1.5

1.4

—

Carcinoma in situ of skin of upper limb, including shoulder

108

3.24

8.85

1.6

1.3

—

Bacterial, viral and other infectious agents

137

789

1.76

8.82

2.1

1.6

—

Diplopia

155

923

1.70

8.81

1.5

1.4

—

Abscess of anal and rectal regions

121

673

1.82

8.76

1.6

1.5

—

Corneal ulcer

234

1541

1.53

8.74

1.8

1.4

—

Malignant neoplasm of other and unspecified parts of biliary tract

4.37

8.74

1.1

1.3

—

Carcinoma in situ of skin of scalp and neck

109

3.20

8.72

1.9

1.3

—

Personal history of malignant neoplasm

361

2.14

8.69

1.3

1.1

—

Cryoglobulinemia

18.13

8.69

1.5

1.6

—

Infections with a predominantly sexual mode of transmission

434

3199

1.36

8.68

1.5

1.4

—

Hypermobility syndrome

409

2.07

8.66

1.1

1.4

—

Congenital malformations of heart and great arteries

202

1251

1.59

8.65

2.1

1.7

—

Malignant melanoma of skin, including Hilmo

129

733

1.78

8.64

1.5

1.4

—

Excessive attrition of teeth

738

5856

1.27

8.63

1.8

1.4

—

Varicella [chickenpox]

499

1.96

8.62

1.9

1.7

—

Malignant neoplasm of tonsil

3.93

8.61

1.3

1.5

—

Ocular pain

114

627

1.85

8.58

1.6

1.4

—

Spondylopathies

904

4352

1.25

8.54

1.3

1.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

494

3731

1.33

8.44

1.5

—

Disseminated intravascular coagulation [defibrination syndrome]

9.28

8.44

3.0

1.3

—

Other disorders of iris and ciliary body

161

2.74

8.40

1.9

1.4

—

Other symptoms and signs involving cognitive functions and awareness

467

3183

1.34

8.37

1.3

1.4

—

Other diseases of oesophagus

101

538

1.90

8.37

1.6

1.4

—

Fitting and adjustment of other devices

267

1639

1.48

8.35

1.4

1.2

—

Injuries to unspecified part of trunk, limb or body region

135

787

1.74

8.34

1.8

1.5

—

Unspecified misadventure during surgical and medical care

348

2.14

8.32

1.7

1.5

—

Other specified and unspecified retinal disorders

191

2.57

8.30

2.2

1.3

—

Presence of other devices

194

1234

1.58

8.28

1.6

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

123

689

1.79

8.27

2.3

1.8

—

Cerebral aneurysm, nonruptured

102

548

1.89

8.27

1.6

1.4

—

Adult-onset Still disease

8.00

8.24

1.2

1.4

—

Pneumothorax

430

2.01

8.24

1.7

1.4

—

Polyuria

231

1538

1.51

8.20

1.4

—

Contact with and exposure to communicable diseases

482

3632

1.33

8.18

1.5

—

Other disorders of bone

252

1710

1.49

8.17

1.6

1.4

—

Macular pucker

139

821

1.71

8.16

1.5

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

227

1508

1.52

8.16

1.5

—

Infarction of spleen

7.73

8.14

1.7

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

544

2431

1.32

8.13

1.3

1.4

—

Rapidly progressive nephritic syndrome

12.52

8.13

1.5

—

Other juvenile arthritis

393

2.06

8.10

1.6

—

Benign neoplasm: Caecum

112

625

1.81

8.04

1.3

1.4

—

Allergic bronchopulmonary aspergillosis (ABPA)

14.09

8.04

2.4

1.5

—

Certolizumab pegol

137

2.87

8.03

1.1

1.4

—

Diseases of the myoneural junction and muscle

140

833

1.70

8.03

1.4

1.5

—

Medical treatment for female infertility

287

1992

1.44

8.02

1.3

1.4

—

Viral agents as the cause of diseases classified to other chapters

195

2.54

8.01

2.2

1.6

—

Spondylopathies (FG)

177

1118

1.60

8.00

1.3

1.4

—

Malnutrition

160

2.72

8.00

2.3

1.8

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.85

7.99

1.5

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

118

671

1.78

7.97

1.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

626

4877

1.28

7.97

1.7

1.5

—

Problems related to lifestyle

140

836

1.69

7.93

1.5

1.3

—

Amenorrhoea

113

636

1.80

7.93

1.3

1.4

—

Pneumococcal septicemia

245

2.34

7.92

1.8

1.5

—

Other shoulder lesions

120

687

1.77

7.92

1.4

—

Other prurigo

4.20

7.90

1.8

1.3

—

Dizziness and giddiness

865

5575

1.23

7.89

1.4

—

Acne vulgaris

149

907

1.67

7.89

1.9

1.4

—

Juvenile arthritis (FINNGEN)

438

1.98

7.89

1.7

1.6

—

Neuromuscular dysfunction of bladder

108

600

1.82

7.89

1.9

1.3

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

203

1328

1.54

7.86

1.5

1.6

—

Malignant neoplasm of eye, brain and central nervous system

265

2.27

7.82

1.3

1.5

—

Other immunodeficiencies

3.50

7.80

1.6

—

Postzoster neuralgia

3.97

7.77

1.3

—

Malignant cancer of tonsil and base of tongue

3.22

7.76

1.2

1.4

—

Pain in thoracic spine

190

1229

1.56

7.76

1.4

1.5

—

Polyhydramnios

352

2.08

7.72

1.4

1.3

—

Intestinal adhesions without obstruction

461

1.93

7.72

1.5

1.4

—

Dentofacial anomalies [including malocclusion]

928

6124

1.22

7.69

1.5

1.4

—

Familial hypercholesterolemia

136

813

1.69

7.65

1.8

1.4

—

Attention to artificial openings

181

2.53

7.62

1.8

1.3

—

Degenerative macular diseases

104

577

1.82

7.61

1.5

1.3

—

Benign neoplasm: Ascending colon

138

830

1.68

7.61

1.5

1.4

—

Need for immunization against other single infectious diseases

15.80

7.61

2.5

1.2

—

Melanocytic naevi of lower limb, including hip

301

2.17

7.60

1.7

1.4

—

Malignant neoplasm of small intestine, including Hilmo

135

2.80

7.60

1.5

1.3

—

Other/unspecified reactive arthropathies

479

1.91

7.57

1.3

1.5

—

COPD

435

2672

1.34

7.56

1.5

1.4

—

Thyrotoxicosis, other and/or unspecified

229

1550

1.49

7.55

1.4

—

Ischaemic Stroke, excluding all haemorrhages

538

3095

1.30

7.51

1.6

1.4

—

Malignant neoplasm, without specification of site, including Hilmo

176

2.53

7.50

1.2

1.3

—

Other and unspecified glaucoma

335

2.09

7.50

1.7

1.3

—

Soft tissue disorders related to use, overuse and pressure

285

2013

1.42

7.49

1.5

1.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

545

1.84

7.49

1.4

1.5

—

Respiratory disorders in diseases classified elsewhere

3.46

7.48

1.7

1.3

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

137

2.80

7.47

1.1

1.5

—

Malignant neoplasm of oropharynx

3.53

7.47

1.3

1.5

—

Hypoparathyroidism

183

2.51

7.47

1.4

1.3

—

Restrictive cardiomyopathy

8.16

7.46

2.2

1.5

—

Otitis externa

275

1936

1.43

7.39

1.7

1.4

—

Oesophagitis

318

2.11

7.35

1.5

—

Fracture of rib(s), sternum and thoracic spine

315

2272

1.39

7.34

1.5

—

Other condition

187

1222

1.55

7.34

1.9

1.5

—

Injuries to the head

1460

7685

1.17

7.33

1.5

—

Nail disorders

109

622

1.78

7.32

1.8

1.5

—

Malignant neoplasm of tonsil, including Hilmo

3.39

7.32

1.3

1.5

—

Varicella [chickenpox]

408

1.98

7.32

1.9

1.6

—

Heartburn

120

703

1.72

7.32

1.5

1.4

—

Shoulder lesions

857

4236

1.23

7.31

1.5

1.4

—

Ovarian cyst

444

1925

1.34

7.31

1.4

1.3

—

Other nutritional anaemias

5.99

7.31

1.7

1.4

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.45

7.29

3.1

1.2

—

Malignant neoplasm of brain

210

2.38

7.27

1.2

1.5

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

216

2.36

7.27

1.7

1.4

—

Drug-induced osteoporosis with pathological fracture

3.22

7.23

1.5

1.3

—

Female infertility

393

1767

1.36

7.23

1.3

1.4

—

Malignant melanoma of skin

100

558

1.81

7.21

1.5

1.4

—

Injury of unspecified body region

552

1.82

7.20

1.9

1.4

—

Mixed hyperlipidaemia

230

2.30

7.18

1.5

1.4

—

Hordeolum and other deep inflammation of eyelid

453

1.91

7.16

1.5

1.4

—

Lichen simplex chronicus

206

2.38

7.11

1.7

1.4

—

Necrobiosis lipoidica, not elsewhere classified

4.64

7.10

2.2

1.3

—

Migraine with aura and triptan purchases

233

1605

1.47

7.09

1.2

1.4

—

Thyrotoxicosis

272

1926

1.42

7.09

1.4

—

Selective serotonin reuptake inhibitors

1318

5848

1.18

7.08

1.3

1.5

—

Type 1 diabetes, definitions combined

165

1056

1.58

7.07

2.1

1.5

—

Anuria and oliguria

6.17

7.06

2.1

1.5

—

Polyarteritis nodosa

6.16

7.05

1.4

1.3

—

Maternal care for known or suspected malpresentation of fetus

247

1237

1.46

7.03

1.3

1.4

—

Disorders of optic nerve, not elsewhere classified

113

2.91

7.03

1.5

1.4

—

Fissure and fistula of anal and rectal regions

265

1871

1.43

7.02

1.4

—

Medical abortion

714

3108

1.25

7.01

1.3

—

Moderate visual impairment, binocular

124

2.79

7.00

1.6

1.4

—

Other mycoses, not elsewhere classified/unspecified

108

2.97

6.99

1.6

1.3

—

Anosmia

3.55

6.99

1.3

1.1

—

Acquired pure red cell aplasia [erythroblastopenia]

8.91

6.99

1.4

1.5

—

Iron deficiency

234

2.28

6.95

1.4

1.5

—

Otitis externa, unspecified

150

945

1.61

6.95

1.7

1.5

—

Abnormal involuntary movements

156

992

1.59

6.93

1.4

—

Acute laryngitis and tracheitis

178

1147

1.54

6.92

1.7

1.4

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

155

2.61

6.90

2.1

1.7

—

Bullous disorders

333

2.04

6.90

1.8

1.4

—

Benign neoplasm: Pancreas

143

2.65

6.85

1.4

1.3

—

Autoimmune hyperthyroidism

368

1.98

6.85

1.3

—

Disorders of optic nerve and visual pathways

127

773

1.66

6.78

1.7

1.5

—

Other chronic obstructive pulmonary disease

409

2555

1.33

6.76

1.5

1.4

—

Status post-ami

219

1137

1.48

6.75

1.6

1.3

—

Scleritis and episcleritis

420

1.91

6.72

1.6

1.4

—

Female infertility, cervical, vaginal, other or unspecified origin

356

1713

1.36

6.71

1.4

—

Coeliac disease

153

977

1.58

6.70

1.6

1.5

—

Speech and linguistic disorders

170

1068

1.55

6.68

2.3

1.7

—

All dysplastic lesions of the vulva

244

2.21

6.68

1.6

1.3

—

Persistent mood disorders

222

1533

1.46

6.67

1.5

1.4

—

Other and unspecified disorders of skin and subcutaneous tissue

386

1.94

6.65

1.3

—

Other salmonella infections

219

2.28

6.63

1.3

1.4

—

Xerosis cutis

3.34

6.63

1.7

1.4

—

Folate deficiency anaemia

4.31

6.62

1.7

1.4

—

Sequelae of cerebrovascular disease

311

1959

1.38

6.62

1.5

1.4

—

Juvenile rheumatoid arthirtis

158

2.53

6.59

1.6

1.5

—

Gangrene, not elsewhere classified

5.58

6.58

2.6

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

356

2656

1.34

6.58

1.4

—

Abnormal findings in nipple discharge synovial fluid wound secretions

101

2.97

6.57

1.6

1.5

—

Malignant neoplasm of oropharynx, including Hilmo

101

2.95

6.54

1.7

1.4

—

Henoch-Schönlein purpura nephritis (HSPN)

6.56

6.53

2.9

1.3

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

3.13

6.52

1.2

1.4

—

Hyperhidrosis

153

2.53

6.47

1.5

1.4

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

15.87

6.47

3.6

1.3

—

Nonspecific lymphadenitis

433

1.87

6.45

1.3

1.5

—

Vitamin deficiency, wide

301

2.06

6.44

1.5

1.4

—

Vitamin deficiency

301

2.06

6.44

1.5

1.4

—

Sequelae of other external causes

377

1.94

6.43

1.8

1.4

—

Disorders of globe

113

2.80

6.42

1.9

1.4

—

Malignant neoplasm of brain, including Hilmo

308

2.04

6.42

1.3

1.5

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

144

915

1.58

6.42

1.2

1.4

—

Dementia, including avohilmo

190

1917

0.68

6.41

1.2

1.3

—

Other (seronegative) rheumatoid arthritis, wide

186

1251

1.50

6.41

1.3

1.4

—

Trigger finger

157

1019

1.55

6.40

1.8

1.4

—

Other aneurysm

288

2.08

6.40

2.5

1.4

—

Type 1 diabetes, strict (exclude DM2)

163

1066

1.54

6.39

2.1

1.5

—

Other and unspecified acne

114

2.82

6.38

2.0

1.6

—

Benign neoplasm: Sigmoid colon

181

1212

1.50

6.37

1.6

1.4

—

Volvulus

125

2.69

6.36

1.4

—

Benign neoplasm: Duodenum

137

2.62

6.35

1.3

1.4

—

Lung cancer and mesothelioma

139

748

1.60

6.34

1.2

1.4

—

Glaucoma

518

3518

1.27

6.34

1.7

1.4

—

Primary hyperparathyroidism

105

619

1.71

6.33

1.6

1.3

—

Other salmonella infections

277

2.09

6.28

1.3

1.4

—

Morphin

3.05

6.28

1.2

1.3

—

Seminoma of testis, including Hilmo

3.65

6.25

1.4

—

Respiratory tuberculosis, confirmed

3.12

6.24

1.2

1.4

—

Other disorders of pigmentation

251

2.15

6.24

1.4

—

Injuries to the knee and lower leg

1548

7481

1.15

6.19

1.5

—

LSIL lesion of the vulva

157

2.47

6.16

1.7

1.3

—

Other disorders starting during childhood or adolescence

114

688

1.67

6.16

2.3

1.9

—

Cerebral palsy and other paralytic syndromes

132

832

1.60

6.14

1.5

—

Paracetamol or NSAID medication

266

952

1.42

6.13

1.5

1.7

—

Other keratitis

144

928

1.57

6.11

1.7

1.4

—

Arthrosis

779

3518

1.22

6.10

1.4

—

Malignant neoplasm of endocrine gland

405

1.87

6.10

1.6

1.4

—

Adhesive capsulitis of shoulder

167

1111

1.51

6.09

1.8

1.4

—

Disorders of iron metabolism

100

2.89

6.08

1.5

—

Other female pelvic inflammatory diseases

166

1104

1.52

6.07

1.4

1.3

—

Tuberculosis, IBD comorbidity

335

1.96

6.07

1.2

1.3

—

Drug-induced aplastic anaemia

13.06

6.05

1.5

1.3

—

Unstable angina pectoris

306

1782

1.36

6.05

1.4

1.3

—

Intracerebral haemorrhage

108

650

1.67

6.02

1.7

1.3

—

Other endocrine disorders

552

1.73

6.02

2.7

1.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

1187

7225

1.17

6.01

1.4

1.5

—

Autonomic disorders

135

2.58

6.01

1.8

1.5

—

Secondary polycythaemia

135

2.58

6.01

1.4

—

Certain zoonotic bacterial diseases

112

2.75

5.99

1.2

1.3

—

Disorders of psychological development

214

1391

1.44

5.98

2.1

1.6

—

Other bacterial agents as the cause of diseases classified to other chapters

3.52

5.95

2.1

1.6

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.19

5.95

1.2

1.4

—

Acute appendicitis

874

6865

1.19

5.94

1.5

—

Diseases of appendix

930

7082

1.19

5.92

1.5

—

Fitting and adjustment of external prosthetic device

12.04

5.92

3.2

1.2

—

Injuries to the hip and thigh

482

3450

1.27

5.92

1.5

1.4

—

Polycythaemia vera

142

2.51

5.89

1.5

1.3

—

COPD, hospital admissions

408

2668

1.30

5.89

1.5

1.4

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

9.77

5.89

1.6

1.2

—

Superficial injury of lower leg

301

2240

1.35

5.89

1.6

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

192

2.28

5.88

1.5

—

Peptic ulcer

3.91

5.87

1.2

1.4

—

Single delivery by caesarean section

264

1090

1.40

5.87

1.3

1.5

—

Injuries to the wrist and hand

1292

7745

1.16

5.87

1.5

—

Whooping cough

2.95

5.86

1.8

1.5

—

Corticotropin deficiency

3.76

5.85

1.4

1.5

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

3.07

5.85

1.3

—

Other localized connective tissue disorders

102

2.81

5.85

1.7

1.3

—

Panniculitis, unspecified

3.72

5.83

1.4

1.5

—

Unspecified fall

581

4637

1.24

5.82

1.5

—

Methotrexate

136

875

1.57

5.80

1.2

1.4

—

Injuries to the shoulder and upper arm

1001

6863

1.18

5.77

1.5

—

Malignant neoplasm of mesothelium and soft tissue

187

2.28

5.77

1.8

1.3

—

Clear cell adenocarcinoma of kidney

226

2.16

5.76

1.8

1.4

—

Other complications of labour and delivery, not elsewhere classified

184

1159

1.47

5.75

1.2

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

298

2225

1.35

5.74

1.5

1.4

—

Psoriatic and enteropathic arthropathies

128

815

1.58

5.73

1.3

1.5

—

169

2.36

5.73

2.3

1.5

—

Specific development disorders of scholastic skills

548

1.73

5.73

2.3

1.7

—

Appendicitis, broad definition

921

7057

1.18

5.71

1.5

—

Monoplegia

2.96

5.69

1.6

1.3

—

Malignant neoplasm of pancreas, including Hilmo

357

1.89

5.69

1.1

1.4

—

Crossbite

128

755

1.59

5.68

2.5

1.7

—

KRA_PSY_EATING, excluding more controls

132

845

1.57

5.68

1.5

1.4

—

Malignant cancer of tonsil and base of tongue, including Hilmo

127

2.58

5.67

1.3

1.4

—

Asthma and allergy, excluding more controls

161

1066

1.50

5.67

1.3

—

Right hemicolectomy

295

1.99

5.66

1.4

—

Bipolar affective disorders

246

1786

1.39

5.66

1.3

1.4

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

579

1.69

5.65

1.6

1.3

—

Atrophic disorders of skin

148

977

1.53

5.64

1.5

1.3

—

COPD, early/later onset

410

2692

1.29

5.63

1.5

1.4

—

Intracranial trauma

737

4296

1.21

5.63

1.4

1.5

—

Bell's palsy

131

843

1.57

5.62

1.8

1.4

—

Disorders of synovium and tendon

618

4426

1.23

5.60

1.5

1.4

—

Coronary artery bypass grafting

213

1117

1.43

5.59

1.8

1.3

—

Premature rupture of membranes

268

1404

1.37

5.58

1.3

1.4

—

Disturbance of activity and attention

213

1484

1.42

5.58

1.7

1.5

—

Hypertension, Pulmonary Arterial

3.76

5.56

1.3

1.4

—

Multiple gestation

116

728

1.61

5.55

1.3

1.4

—

Epilepsy

354

2713

1.31

5.53

1.5

1.6

—

Left ventricular outflow tract obstruction, narrow definition

464

1.78

5.52

2.2

1.8

—

Tuberculosis, wide

361

1.87

5.52

1.3

—

Concussion

629

4208

1.22

5.51

1.4

1.5

—

Embedded and impacted teeth

442

2880

1.27

5.50

1.8

1.4

—

Other bacterial agents as the cause of diseases classified to other chapters

3.05

5.49

2.0

1.5

—

Behçet disease

8.59

5.49

1.5

1.2

—

Other surgical follow-up care

198

2.21

5.48

1.7

1.3

—

Papulosquamous disorders

419

3297

1.28

5.47

1.5

1.4

—

Twin gestation

112

700

1.62

5.46

1.3

1.4

—

Car occupant injured in noncollision transport accident

286

2.00

5.46

1.4

—

Benign neoplasm: Rectum

171

1172

1.47

5.44

1.6

1.4

—

Other and unspecified nail disorders

124

2.56

5.42

1.2

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

998

5755

1.17

5.42

1.4

—

Malignant neoplasm of colon, including Hilmo

130

841

1.55

5.41

1.3

1.4

—

3.03

5.40

1.3

—

Barrett oesophagus

280

1.99

5.39

1.3

1.4

—

Fall on same level involving ice and snow

650

5374

1.21

5.38

1.5

1.4

—

Viral meningitis

274

2.01

5.36

1.2

1.4

—

Pediculosis, acariasis and other infestations

490

1.74

5.36

1.7

1.5

—

Atopic dermatitis, strict definition

438

3403

1.27

5.36

1.5

—

Fracture of shoulder and upper arm

393

3075

1.28

5.32

1.6

1.5

—

Abnormalities of gait and mobility

123

791

1.57

5.32

1.6

1.4

—

Cardiomyopathy in other diseases

6.24

5.32

1.2

1.4

—

Campylobacter enteritis

175

2.28

5.31

1.6

1.3

—

Underdevelopment of the second kidney

8.51

5.30

2.5

1.9

—

Urolithiasis

334

2564

1.31

5.30

1.7

1.4

—

Malignant neoplasm of nasal cavity and sinuses

6.18

5.30

1.3

—

Complications of other internal prosthetic devices, implants and grafts

214

2.13

5.30

1.9

1.4

—

Male infertility

396

1.82

5.29

1.8

1.7

—

Mouth breathing

472

3778

1.25

5.29

1.7

1.5

—

Benign neoplasm: Rectum, anus and anal canal

187

1311

1.44

5.28

1.6

1.4

—

Pneumonia due to Streptococcus pneumoniae

241

2.06

5.28

1.7

1.5

—

Alport

8.39

5.28

3.6

1.5

—

Essential (haemorrhagic) thrombocythaemia

182

2.23

5.25

1.2

1.3

—

Other forms of systemic lupus erythematosus

3.48

5.25

1.3

1.6

—

Congenital malformations of aortic and mitral valves

391

1.83

5.23

2.1

1.7

—

Fall on and from stairs and steps

285

2145

1.34

5.22

1.4

—

Cervicalgia

217

1565

1.39

5.22

1.5

—

Scleritis

3.02

5.21

1.8

1.4

—

Hyperkinetic disorders

224

1593

1.39

5.20

1.7

1.6

—

Acute drug-induced interstitial lung disorder

5.06

5.20

1.3

—

Psoriasis vulgaris

212

1525

1.40

5.20

1.5

—

Helminthiases

109

2.64

5.20

1.7

1.5

—

Asthma and allergy

161

1087

1.47

5.18

1.3

—

Other proliferative retinopathy

6.02

5.17

3.0

1.1

—

Severe visual impairment, binocular

6.66

5.17

1.9

1.4

—

Tonsillectomy and adenotomy

833

4903

1.19

5.16

1.6

1.5

—

Seronegative rheumatoid arthritis

105

655

1.62

5.16

1.2

1.4

—

Other arthrosis

523

2929

1.24

5.14

1.5

1.4

—

Impotence

378

1.83

5.13

1.9

1.5

—

Rotator cuff syndrome

632

3742

1.22

5.12

1.5

1.4

—

Hydrocele

127

830

1.54

5.12

1.9

1.5

—

Disorders of refraction and accommodation

356

2761

1.29

5.11

1.9

1.5

—

Other/unspecified seropositive rheumatoid arthritis

243

1793

1.36

5.08

1.3

1.4

—

Sleep disorders, other/unspecified

294

1.94

5.07

1.6

1.4

—

Papilloedema, unspecified

179

2.23

5.07

2.2

1.5

—

Dementia

179

1744

0.70

5.06

1.2

1.3

—

Dental pulpitis, including avohilmo

1221

6907

1.15

5.06

1.4

1.5

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

240

1769

1.36

5.06

1.3

1.4

—

Other noninfective disorders of lymphatic vessels and lymph nodes

205

2.13

5.05

1.8

1.5

—

Personality disorders

361

2821

1.29

5.04

1.3

1.4

—

Alzheimer disease, including avohilmo

121

1296

0.65

5.02

1.3

1.2

—

Viral encephalitis, not elsewhere classified/unspecified

123

2.50

5.02

1.3

—

Malignant neoplasm of adrenal gland, including Hilmo

3.82

5.00

1.9

1.6

—

Malignant neoplasm of eye and adnexa, including Hilmo

3.10

4.99

1.2

1.5

—

Faecal incontinence

410

1.77

4.99

1.3

—

Gestational [pregnancy-induced] hypertension

304

2321

1.31

4.98

1.4

1.3

—

Psoriasis

315

2422

1.31

4.98

1.5

—

Spirochaetal infections, other/unspecified

600

1.63

4.98

1.3

1.4

—

Other misadventures during surgical and medical care

142

2.38

4.97

2.2

1.4

—

Secondary systemic amyloidosis

8.34

4.97

1.8

1.3

—

Other and unspecified myopathies

531

1.67

4.97

1.4

—

Obsessive-compulsive disorder

103

648

1.61

4.95

1.5

1.4

—

Ulcer of oesophagus

353

1.83

4.94

1.5

1.4

—

Malignant neoplasm of testis

112

2.57

4.94

1.4

1.3

—

Carcinoma in situ of skin of ear and external auricular canal

3.29

4.93

2.2

1.3

—

Monocytic leukaemia

5.69

4.93

1.8

1.4

—

Migraine without aura and triptan purchases

230

1694

1.37

4.92

1.4

—

Aortic aneurysm

195

1369

1.40

4.91

1.8

1.3

—

Suppurative and necrotic conditions of lower respiratory tract

347

1.84

4.91

1.8

1.5

—

Seropositive rheumatoid arthritis, wide

245

1821

1.35

4.91

1.3

1.4

—

Myocardial infarction, with ST-elevation

148

1008

1.48

4.90

1.6

1.4

—

Other specified/unspecified soft tissue disorders

255

1.98

4.90

1.4

1.3

—

Acute appendicitis, no complications

696

5820

1.19

4.90

1.5

—

Overexertion and strenuous or repetitive movements

119

776

1.55

4.88

1.4

1.5

—

Mental and behavioural disorders due to psychoactive substance use

731

5713

1.19

4.87

1.4

1.5

—

Disorders of adult personality and behaviour

385

3047

1.27

4.87

1.3

1.4

—

UC patients in KELA-register (code 208), prior to 1994

263

1.97

4.86

1.3

1.5

—

Other and unspecified bullous disorders

3.17

4.86

2.2

1.3

—

Tooth eruption problems

251

1831

1.35

4.86

2.0

1.5

—

Calculus of kidney and ureter

310

2387

1.31

4.86

1.7

1.4

—

Other and unspecified disorders of vitreous body

368

2855

1.28

4.85

1.5

1.4

—

Other noninflammatory disorders of vulva and perineum

108

690

1.58

4.85

1.4

—

Other symptoms and signs involving the urinary system

110

706

1.57

4.84

1.8

1.4

—

Perioral dermatitis

119

2.49

4.84

1.8

1.5

—

Appendectomy

798

6490

1.18

4.83

1.5

—

Other congenital malformations

131

875

1.51

4.82

1.8

1.7

—

Granulomatous disorders of skin and subcutaneous tissue

157

2.27

4.80

2.4

1.5

—

Other extrapyramidal and movement disorders in other diseases

227

1675

1.36

4.79

1.5

1.4

—

Implicit parasitic Sepsis

4.92

4.78

1.7

1.3

—

Selective deficiency of immunoglobulin A [IgA]y

4.62

4.77

1.6

1.3

—

Social phobias

127

845

1.52

4.77

1.4

1.5

—

Complications of genitourinary prosthetic devices, implants and grafts

126

2.42

4.76

2.4

1.3

—

Other and unspecified disorders of autonomic nervous system

5.37

4.76

1.3

—

Astigmatism

561

1.64

4.74

2.1

1.6

—

Arthropathy in ulcerative colitis

2.79

4.74

1.2

1.4

—

Myocardial infarction, unclassifiable

164

1020

1.44

4.74

1.6

1.3

—

Defects in the complement system

3.26

4.74

1.3

1.7

—

Disorders of phosphorus metabolism and phosphatases

3.72

4.73

1.6

1.5

—

Malignant neoplasm of accessory sinuses, including Hilmo

7.52

4.72

1.2

1.1

—

Family history of other conditions

103

2.60

4.69

1.5

1.1

—

Rheumatism, unspecified

123

815

1.52

4.68

1.2

1.4

—

Other other unspecified disorders of the circulatory system

198

2.10

4.68

1.7

1.5

—

Enthesopathies of lower limb, excluding foot

244

1828

1.34

4.67

1.5

—

Episcleritis

353

1.81

4.66

1.7

1.4

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

8.81

4.66

1.9

1.4

—

Benign neoplasm: Small intestine

212

2.06

4.65

1.3

1.4

—

Enteropathic arthropathies

153

2.27

4.64

1.2

1.5

—

Other bullous disorders

166

2.21

4.63

1.9

1.4

—

Superficial injury of head

260

1968

1.33

4.63

1.4

1.5

—

Erythema nodosum

166

2.21

4.63

1.6

1.4

—

Alzheimer disease

1109

0.64

4.63

1.3

1.2

—

Drug-induced thyroiditis

7.37

4.61

1.3

1.4

—

Follow-up examination after treatment for malignant neoplasms

458

1.69

4.60

1.4

1.3

—

Benign neoplasm: Kidney

193

2.11

4.59

1.3

1.4

—

Atypical mycobacterium lung infection

3.14

4.57

1.1

1.3

—

Certain conditions originating in the perinatal period

161

1003

1.44

4.56

2.2

1.6

—

Congenital vesicoureteral reflux

2.78

4.54

4.0

1.4

—

Hypopituitarism

101

647

1.58

4.53

1.9

1.7

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

499

1.66

4.52

1.9

1.3

—

Temporomandibular joint disorders, including avohilmo

554

4531

1.21

4.52

1.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.35

4.51

1.2

1.5

—

Use of memantine

1010

0.60

4.50

1.2

—

Use of other anti-dementia drugs

1010

0.60

4.50

1.2

—

Cutaneous lupus erythematosus

136

2.32

4.49

1.4

—

Routine general health check-up of defined subpopulation

105

2.52

4.49

1.5

1.2

—

Persons encountering health services in circumstances related to reproduction

750

4289

1.18

4.48

1.6

—

Malignant neoplasm, without specification of site

111

2.46

4.48

1.1

1.2

—

Polyclonal hypergammaglobulinaemia

13.87

4.47

1.7

1.3

—

Dermatopolymyositis, unspecified

4.90

4.46

1.2

1.4

—

Female infertility, associated with anovulation

118

786

1.52

4.44

1.2

1.4

—

Mixed and other personality disorders

105

682

1.56

4.44

1.2

1.5

—

Erythema intertrigo

118

2.42

4.43

2.0

1.3

—

Maternal care for cervical incompetence

258

1.93

4.43

1.5

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

505

1.65

4.43

1.8

1.5

—

Other specified and unspecified disorders of eye and adnexa

230

1.99

4.43

1.6

1.4

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

6.86

4.43

1.2

1.4

—

Sweet's syndrome

13.19

4.41

1.1

1.3

—

Metabolic disorder, other/unspecified

4.92

4.41

1.5

—

Malignant neoplasm of thyroid gland, including Hilmo

419

1.71

4.40

1.6

1.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

229

1718

1.34

4.39

1.5

1.4

—

Sleep disorders

1104

6989

1.14

4.38

1.3

1.5

—

Disorders of endocrine glands in diseases classified elsewhere

6.07

4.37

3.8

1.4

—

Implicit parasitic Sepsis

5.79

4.36

1.9

1.4

—

Hypersensitivity pneumonitis due to organic dust

2.65

4.35

1.7

1.4

—

Cluster headache, strict

274

1.89

4.35

1.4

1.5

—

Scabies

392

1.73

4.32

1.8

1.5

—

Abnormal blood-pressure reading, without diagnosis

296

1.85

4.32

1.7

1.5

—

Nummular dermatitis

529

1.62

4.31

1.8

1.4

—

Disorders of porphyrin and bilirubin metabolism

2.71

4.30

1.4

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

140

803

1.46

4.30

1.2

1.4

—

Separation of retinal layers (serosa)

268

1.89

4.30

2.1

1.5

—

Placental disorders

2.93

4.29

1.2

1.5

—

Tick-borne viral encephalitis

5.10

4.28

1.0

1.5

—

Complications peculiar to reattachment and amputation

4.30

4.28

2.3

1.4

—

Other and specified injuries of hip and thigh

133

2.30

4.26

1.6

1.4

—

Other endophthalmitis

5.04

4.26

1.6

1.4

—

Emotionally unstable personality disorder

175

1266

1.39

4.25

1.3

1.4

—

malignant neoplasm of female genital organs

628

1.56

4.25

1.1

1.3

—

Cluster headache, wide

291

1.85

4.23

1.4

1.5

—

Osteomyelitis of vertebra

6.32

4.23

1.6

1.4

—

Malignant neoplasm of nasopharynx, including Hilmo

7.24

4.22

1.2

1.1

—

Alzheimer’s disease, strict definition

905

0.60

4.21

1.3

1.2

—

Hidradenitis suppurativa

270

1.88

4.21

1.7

1.5

—

Antenatal screening

272

1167

1.32

4.20

1.4

—

Other benign neoplasms of skin

350

2793

1.26

4.18

1.7

1.4

—

Antepartum haemorrhage, not elsewhere classified

107

708

1.53

4.17

1.4

1.3

—

Superficial injury of ankle and foot

166

1195

1.40

4.17

1.7

1.5

—

Scar conditions and fibrosis of skin

271

1.87

4.16

1.4

1.3

—

Radial styloid tenosynovitis [de Quervain]

396

1.71

4.16

1.4

—

Malignant neoplasm of adrenal gland

4.92

4.16

1.7

2.0

—

Tuberculosis of other organs, strict

2.57

4.15

1.6

1.4

—

Malignant neoplasm of colon

628

1.55

4.14

1.3

1.4

—

Febrile neutrophilic dermatosis [Sweet]

11.29

4.14

1.1

1.3

—

Menorrhagia

370

1636

1.26

4.11

1.4

—

Conotruncal defects

190

2.08

4.10

2.5

2.1

—

Pneumonitis due to solids and liquids

466

1.64

4.10

1.4

—

ILD and respiratory illness in diseases classified elsewhere

4.43

4.10

1.5

1.4

—

Papillary adenocarcinoma of thyroid gland

265

1.87

4.10

1.6

1.4

—

Anomalies of dental arch relationship, including avohilmo

275

1925

1.30

4.09

2.0

1.4

—

Chronic diseases of tonsils and adenoids

1035

5729

1.14

4.09

1.6

1.5

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

6.01

4.08

1.2

1.4

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

4.09

4.08

3.1

1.6

—

Alcohol-induced chronic pancreatitis

452

1.66

4.08

1.7

1.5

—

Mental disorders, not otherwise specified

111

745

1.51

4.07

1.5

1.4

—

Hypertensive encephalopathy

6.78

4.05

1.7

1.2

—

Benign neoplasm of urinary organs

259

1.88

4.05

1.4

—

Unspecified/other endometriosis

114

770

1.49

4.04

1.2

1.4

—

Other eating disorders

547

1.59

4.03

1.6

1.4

—

Ingrowing nail

393

1.70

4.01

2.1

1.5

—

Sacroiliitis, not elsewhere classified

416

1.68

4.01

1.3

1.4

—

Other and unspecified haemorrhagic conditions

2.59

4.01

2.4

1.5

—

Car occupant injured in other and unspecified transport accidents

237

1813

1.32

4.00

1.5

1.4

—

Deficiency of other B group vitamins

2.57

3.99

1.2

1.5

—

Postmenopausal osteoporosis with pathological fracture

246

1.89

3.98

1.3

1.2

—

Open bite

573

1.58

3.98

2.3

1.6

—

Fibrosis and sclerosis of liver

10.55

3.97

1.9

1.1

—

Aneurysms, operations, SAH

147

1045

1.41

3.96

1.5

1.4

—

Nontraumatic intracranial haemmorrhage

159

1145

1.39

3.96

1.6

1.4

—

Malignant neoplasm of bone and articular cartilage

2.98

3.95

1.2

1.4

—

Other dermatomyositis

5.02

3.94

1.2

1.5

—

Haemorrhagic disorder due to circulating anticoagulants

3.32

3.93

1.4

1.3

—

Bronchiectasis

433

1.65

3.93

1.5

1.3

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.57

3.90

1.4

—

Anogenital herpesviral [herpes simplex] infection

149

1067

1.41

3.89

1.4

1.3

—

Hereditary hypogammaglobulinemia

6.35

3.89

2.7

1.3

—

Pyothorax

256

1.86

3.87

1.8

1.5

—

Colonic or urogenital fistula

283

2225

1.28

3.87

1.4

—

Unspecified human immunodeficiency virus [HIV] disease

2.62

3.87

1.1

1.6

—

Familial hypercholesterolemia, with ischemic heart disease

458

1.63

3.87

1.7

1.3

—

Urethritis and urethral syndrome

126

2.26

3.86

1.9

1.4

—

Absence of one kidney

4.58

3.86

2.3

1.6

—

Third [oculomotor] nerve palsy

101

2.43

3.85

2.6

1.5

—

COPD, hospital admissions 1, only main diagnosis

286

1923

1.28

3.85

1.5

1.4

—

Malignant neoplasm of thyroid gland

367

1.71

3.85

1.6

1.4

—

Superficial injury of hip and thigh

140

992

1.42

3.85

1.5

1.4

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS